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ABSTRACT OF THE DISSERTATION 
 
The Reverse Glyoxylate Shunt 
 
by 
 
Sio Si Wong 
Doctor of Philosophy in Chemical Engineering 
University of California, Los Angeles, 2016 
Professor James C. Liao, Chair 
 
 
 
Acetyl-CoA is an essential intermediate in a lot biofuel and biochemical productions. In hope to 
eliminate the carbon loss steps in producing acetyl-CoA from pyruvate, we sought to design and 
implement an alternative pathway in E. coli for more efficient carbon usage and for the reduction 
of CO2 emission during the biochemical production process. In nature, many pathways exist as 
reverse counterparts of each other, such glycolysis and gluconeogenesis, pentose phosphate 
pathways and the Calvin-Benson-Bassham cycle, the tricarboxylic acid cycle and the reductive 
tricarboxylic acid cycle, etc. Inspired by the idea, we designed a reverse glyoxylate shunt to bypass 
the pyruvate decarboxylating step in order to conserve carbon for the production of acetyl-CoA. 
In this work, we designed two similar pathways based on a fully or partially reverse glyoxylate 
shunt for the conversion of carbon from either C4 or C3 into C2. The driving force principle in 
metabolic engineering was employed to reverse the glyoxylate shunt by overexpressing ATP-
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dependent enzymes. In the first reverse glyoxylate shunt (rGS-1), we built the pathway replacing 
enzymes that are intrinsically irreversible with ATP-dependent ones. By optimizing branch point 
in which the native glutamate metabolism drains the intermediate, isocitrate, from our pathway, 
we demonstrated the conversion of malate and succinate into OAA and acetyl-CoA, essentially 
the conversion of a molecule of C4 into a C2 molecule in an aspartate auxotroph. As for second 
reverse glyoxylate shunt (rGS-2), we built upon the rGS-1 with the addition of the glyoxylate 
degradation pathway for recycling glyoxylate back to the C3 molecules. We improved malate 
thiokinase and malyl-CoA lyase coupled activities and showed growth rescues in two strains, 
including enhanced growth rate in an acetyl-CoA auxotroph. The two reverse glyoxylate shunts 
posed potential solution to the inefficient carbon usage and with further development of CO2 
fixation enzymes, are capable of being a building block of a CO2 fixation pathway. 
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Chapter 1. Introduction - Pathway Manipulation and Design 
 
1.1. Introduction 
Metabolic pathways comprise of a series of enzymatic reactions, which produce certain products 
with different kinds of substrates. Different metabolic pathways produce the same product at the 
expenditure or production of various amounts of ATP and reducing equivalent. Metabolic pathway 
databases, Kyoto Encyclopedia of Genes and Genomes (KEGG) and BioCyc, etc. have enabled in 
silco design of metabolic “chimeric” pathway1 and the genome-scale reconstruction of metabolic 
network.2,3 Given any starting material and end product, it is possible to design a metabolic 
pathway with the currently known reactions4 through detailed analysis of type of reactions 
performed by the given enzymes. 5-9 However, the successful expression of the pathway in the 
target organisms does not guarantee high productivity, or titer or yield of the desired product, 
essentially due to the fact that organisms varied a great deal in terms of substrate, cofactor 
availability. It is, therefore, important to create in vivo driving force, in terms of ATP, reducing 
equivalent, substrate pool or downstream sink targeted to the pathway or the organisms for the 
metabolic pathway design to be successful. Overexpression of the desired enzymes and knocking 
out competing pathways is often not enough for metabolic pathway design, which requires a fine 
tune between the cell metabolism and the incorporated metabolic pathway. In this sense, not only 
is the design of pathway an important factor in incorporating a novel metabolic pathway in the 
target organism, it is also important to have feedback mechanisms that gives information on how 
to better design the pathway. Directed evolution has also been demonstrated as a way to improve 
performance of a specific enzyme10 or even the pathway itself 11. Directed evolution requires an 
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efficient selection scheme12 which will be able to select the “evolved” enzyme according to growth 
rates. In the following part of this chapter, we are going to discuss and review various driving 
forces employed as principles in metabolic pathway design. 
 
 
1.2. Computer-aided Pathway Design 
Computational systems biology with large scale modeling has enabled the analysis and 
optimization of metabolic pathway design and expression, in terms of both reducing toxicity and 
increasing substrate availability13. Computer-aided design through genomic scale modeling has 
also proven to successful in the case of succinate production.14 Metabolic analysis was applied to 
estimate various knockouts of candidate genes for overproduction of succinic acid in E. coli. The 
predicted combinatorial knockout strain of three pyruvate-forming enzymes allowed an increase 
in succinate production by more than seven fold. 
Steady-state dynamic simulation models, for example metabolic ensemble modeling, have been 
developed to model different metabolic networks to aid the design of flux through metabolic 
networks. Various improvements have been applied to simplify the calculation process. 15-19 
Contador et al.,20 for example, used ensemble modeling (EM) to identify the next rate-controlling 
bottleneck for further improving L-lysine production in E. coli. EM has also been used to 
demonstrated the simulation of aromatic production in E. coli 21 It correctly identified the first rate 
limiting step, the transketolase, Tkt, and predicted the enhanced aromatics production through 
overexpression of the phosphoenolpyruvate synthase (Pps) only after a first increase in Tkt.  
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Computer-aided design can be useful for the design of novel pathways but at the same time, the 
huge amount of information requires other principles, whether physical or biochemical, to filter 
out the information that is helpful in improving the pathways. As a result, intuitive design of 
driving force should work in line with computer-aided guidelines to produce the best results. 
 
 
1.3. Metabolic Pathway Design on Reducing Power Aspect 
For pathways involving redox reactions, it is important to consider the choice of enzyme in terms 
of specificity to different electron mediators. NADPH, NADH, reduced ferredoxin, flavodoxin, 
ubiquinol, menaquinol, etc are employed as reducing power sources with different specificity and 
capability. However, the availability of respective reducing equivalents varies among different 
organisms or in the same organism during different growth phases. Native pathways have long 
evolved to use specific electron mediators under certain growth conditions but heterologously 
designed pathways have not adapted to the in vivo environment. It is, therefore, essential to 
consider cofactor specificity so that there are abundant amount of the said cofactor in the target 
host organism.  
Enzymes performing the same redox reactions from different organisms have diversified 
specificity to electron mediators. Designing a pathway that consumes a mediator innate to the host 
organism is an important aspect to consider when choosing among a large number enzymes from 
different organisms for overexpression in the host organism.  For example, the native n-butanol 
production pathway from Clostridium contains the ferredoxin-dependent butyryl-CoA 
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dehydrogenase complex (bcd) yet unlike NADH, ferredoxin is not a commonly used electron 
mediator in E. coli. As a result, the production of n-butanol is not facilitated when expressed in E. 
coli22.  Shen, et al.,23 achieved higher titer and higher yield of the production of n-butanol in E. 
coli by replacing the ferredoxin-dependent bcd with the NADH-dependent trans-enoyl-CoA 
reductase (ter).  Enzyme specificity for reducing power mediators is not limited to small molecules. 
Ferredoxin, which is a protein as well as a reducing power mediator possess different structure 
when it is expressed in different organisms. Another example was shown in hydrogen production 
with hydrogenase where the electron mediator was overexpressed to compensate for the 
insufficient amount in the foreign host. Apagakis, et al 24 constructed a synthetic hydrogen 
metabolism circuit in E. coli using ferredoxin associated hydrogenase and pyruvate:ferredoxin 
oxidoreductase. Their results showed that enzymes with the same function coupled with 
ferredoxins from different origins at various efficiencies and thus affected rate of production of 
hydrogen from pyurvate. Ducat, et al.,25 further demonstrated this idea in Synechococcus elongatus 
by channeling reducing power from photosynthesis to Clostridium acetylbutyricum hydrogenase 
to produce hydrogen. The authors showed that by overexpressing heterologous ferredoxin from C. 
acetylbutyricum, the hydrogen production was increased compared with using S. elongatus 
ferredoxin as the electron mediator. 
Besides changing using enzymes with different specificity to perform the same reaction, increasing 
the availability of reducing power in the target organism is equally important. In the model 
organism, E. coli, the fermentative pathways, namely, lactate, ethanol and succinate production, 
serve as electron sink in the absence of electron acceptors such as oxygen, or nitrate. Knocking 
out the fermentative pathways is detrimental to E. coli grown in minimal medium with glucose 
under fermentative conditions due to the inability to recycle NAD+. Reducing power can then be 
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directed to power the heterologously expressed pathways. This is demonstrated in effort to increase 
succinate production by Jantama, et al., 26 by knocking out lactate dehydrogenase (ldhA) and 
alcohol dehydrogenase(adhE). Shen, et al knocked out  fumarate reductase (frdBC) in addition to 
ldhA, adhE and phosphate acetyltransferase (pta) from E. coli so as to channel reducing power to 
the n-buatnol pathway and alleviated the production titer23. Similar strategies have also been 
employed by Balzer, et al., in the production of succinate in E. coli by knocking out ldhA and adhE 
which consumes NADH. 27 Yim, et al., also knocked out similar enzymes to elevate the production 
of 1,4-butanediol.28 
In addition to knocking out competing pathways that consumes reducing power, direct delivery of 
electrons by overexpressing foreign enzymes is another way of elevating reducing power pool, 
due to the high demand of reducing power source in producing biofuels. Enzymes capable of 
delivering foreign electron source include formate dehydrogenase (fdh) and hydrogenase. Fdh 
catalyzes the oxidation of formate to produce NADH and CO2 whereas hydrogenase catalyzes the 
reversible reduction of NAD+ to NADH by splitting hydrogen into a proton and a hydride ion. 
Berríos-Rivera, et al., first demonstrated the capability of fdh to deliver reducing power from 
formate to NADH in vivo29. Shen et al., overepressed fdh from Candida Boidinii to increase NADH 
pool to produce 1-butanol23 and Dekishima et al., employed the same enzyme to rasie 1-hexanol 
titer30. Same rationale was also seen in n-butanol production by Lim, et al using the fdh from 
Saccharomyces cerevisiae and pyruvate dehydrogenase (pdh) to deliver NADH31.  Similar 
strategies were also employed in succiante production which is also a NADH requiring process. 
Balzer, et al., overespressed fdh to provide reducing power for the oxidative production of 
succinate.27 As for hydrogenases, due to the hazardous nature of hydrogen and the complex 
structure and maturation of hydrogenases, applications of hydrogenases to deliver reducing power 
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were limited. Efforts have been mainly in the application of hydrogeanse to use H+ as the electron 
sink to produce hydrogen and the heterologous overexpression of the hydrogenases. Agapakis, et 
al. overexpresed a ferredoxin-dependent [Fe-Fe] hydrogenase from C. acetylbutylicum in E. coli24 
and Barstow applied the same hydrogenase to couple the reduction of ferredoxin to E. coli central 
metabolism32; Sun, et al., successfully deliver NADPH to E. coli from a [Ni-Fe] hydrogen through 
hydrogeanse from Pyrococcus furiosus 33 and Kuchenreuther demonstrated expression of two 
other [Fe-Fe] hydrogenase from Chlamydomonas reinhardtii and Clostridium pasteurianum34. 
 
1.4. ATP Driving Force in Metabolic Pathway Design 
In central metabolic pathways, the consumption of ATP usually signifies an irreversible step or a 
committed part of the pathway, for instance, phosphoenolpyruvate synthetase in gluconeogenesis, 
6-phosphofructosekinase in glycolysis and acetyl-CoA carboxylase in fatty acid biosynthesis, etc. 
It is mainly because the thermodynamic Gibbs free energy of ATP consumption into ADP is 
largely negative (∆rG’o= -37.6kJ/mol) and thus makes a reaction coupled with consumption of 
ATP a favorable irreversible reaction. 
A successful example demonstrating the design of pathway through addition of ATP-dependent 
steps was shown in the production of n-butanol in the photosynthetic microorganism S. elongatus. 
Initially, with only acetyl-CoA acetyltransferase as the step of converting two molecules of acetyl-
CoA into one molecule of acetoacetyl-CoA as demonstrated in E. coli22, the titer was not high due 
to insufficient reducing power in obligatory aerobic conditions during photosynthesis35. However, 
being inspired by the fatty acid biosynthesis, acetyl-CoA carboxylase, which was ATP-dependent 
has been engineered into S. elongatus36. The irreversible formation of malonyl-CoA allowed 
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accumulation of the intermediate and subsequently led to a higher titer of n-butanol production in 
S. elongatus up to 200mg/mL.  
Using an ATP-dependent enzyme as a driving force or to reverse an initially irreversible has also 
been demonstrated in this work of the reverse glyoxylate shunt as well which is shown in Chapter 
337. It will be discussed in more details how the addition of ATP-dependent enzymes helps to 
reverse enzymatic reactions that were unfavorable without the consumption of ATP. 
 
 
1.5. Conclusion 
Successful pathway design involves somehow a driving force in the pathway, be it ATP or 
reducing equivalents as we discussed in the chapter. In addition to the cofactors balancing of ATP 
and NADH, other driving forces includes the irreversible deamination of amino acids where 
ammonia is lost in the medium and drives the production of biofuel38. The above design principles 
will be further discussed in the Chapter 2 as demonstrated in the microbial production of butanols. 
Chapter 3 and 4 depicts the design principles as mentioned before used in the design of two 
different versions of a reverse glyoxylate shunt. 
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Chapter 2. Microbial Production of Butanols 
Disclaimer: This chapter is reprinted from Book: Industrial Biotechnology – Products and 
Processes, Editors: Christoph Wittmann and James Liao, Chapter: Microbial Production of 
Butanols, Authors: Sio Si Wong, Luo Mi and James C. Liao (Not yet published) Copyright 
Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission. 
 
 
2.1 Abstract 
n-Butanol and isobutanol are fuels and chemicals that can be produced via microbial fermentation 
from renewable resources. n-Butanol production using Clostridium-based acetone-butanol-ethanol 
(ABE) fermentation was among the oldest industrial microbial processes. In light of the increasing 
interest in bio-based fuels and chemicals production, this chapter aims to provide an overview of 
the native n-butanol biosynthesis pathway (ABE fermentation) as well as the engineered pathways 
for n-butanol and isobutanol production using various non-native producers. Strategies for 
improving pathway performance and the utilization of diverse substrates were the focus of 
discussion here. 
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2.2. Introduction 
Microbial production of n-butanol (or 1-butanol) started about a century ago when Chaim 
Weizmann isolated Clostridium acetobutylicum and developed the acetone-butanol-ethanol (ABE) 
fermentation using this organism1,2. This process produced roughly 3:6:1 ratio of acetone, butanol, 
and ethanol. It was among the oldest industrial fermentation practices, but was outcompeted by 
the booming petrochemical processes after World War II2. Recently, the concerns over global 
warming due to greenhouse gas emission as well as the sustainability of energy supply have 
revitalized the interest in sustainable bio-based fuels and chemicals production. n-Butanol and 
isobutanol are among the compounds that can be produced by microbes, and can both serve as 
fuels or as solvents and chemical feedstocks. 
 
n-Butanol and isobutanol are naturally present in a variety of alcoholic beverages such as beer, 
wine and whisky as a byproduct from fermentation. n-Butanol is used as an ingredient in products 
such as perfumes and in the extraction of natural flavoring materials and vegetable oils3. n-Butanol 
also serves many purposes such as a plasticizer, solvent, swelling agent, or as raw material in the 
production of other chemicals including acrylate esters, glycol ethers, n-butyl-acetate, amino resins 
and n-butylamines and its respective Grignard’s reagent4.  Isobutanol is commonly used as an 
industrial solvent in paints, automotive polisher additive, ink ingredients and precursors to isobutyl 
esters such as isobutyl-acetate and diisobutyl phthalate (DIBP).  Isobutanol can also be dehydrated 
to isobutene, which can be used to produce p-xylene and terephthalic acid, or can be oligomerized 
to produce C12 to be used in jet fuel or C16 as biodiesel5. 
The petroleum based production of n-butanol is through the oxo process, which involves first the 
production of n-butyraldehyde by the carboxylation of propylene with carbon monoxide and 
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hydrogen over a rhodium hydrocarbonyl catalyst. Further reduction of n-butyraldehyde with 
hydrogen produces n-butanol.4,6,7 Isobutanol is co-produced with n-butanol in the oxo process or 
through the carbonylation of propylene.7,8 The petroleum based chemical market for n-butanol 
exceeds $5 billion at 3 million tonnes per year, which is six times the size of current isobutanol 
market and the market is still growing. However, if isobutanol is used as transportation fuel, then 
the market will grow dramatically. 
n-Butanol and isobutanol have higher energy densities (27.0 MJ/L and 26.6 MJ/L, respectively) 
than that of ethanol (21.1 MJ/L), and are more compatible with current infrastructure. These 
properties make them attractive alternatives to ethanol as biofuels. However, butanol production 
using the ABE fermentation process yields a relatively low titer of butanol (about 1-2% w/v)9 
compared to that of ethanol from yeast (10-15% w/v) due to butanol toxicity to the microbial strain. 
The low titer makes the purification of butanol more costly than ethanol, and thus, raises the 
production cost. As such, various metabolic engineering efforts have been made both to improve 
native microbial producers and to transfer of the pathway into other microorganisms to explore 
metabolic diversity. In this chapter, we review the ABE fermentation for the production of butanol, 
transfer of the butanol pathways to non-native producers, the keto-acid pathway for the production 
of isobutanol, and efforts in metabolic engineering towards sustainable, high-titer production of 
butanols. 
 
 
2.3. A Historical Perspective of n-Butanol Production   
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The earliest documented butanol production from a microorganism dated back 1861 by Pasteur10. 
However, only until the beginning of the 20th century, the industrial interest finally spurred 
significant research into microbial n-butanol production which ultimately led to the discovery of 
Clostridium acetobutylicum around 1912-191411, a strain later became the workhorse of industrial 
ABE fermentation. The superiority of C. acetobutylicum over other bacterial strains lies in its 
considerable higher solvent yield2 and its capability of utilizing various starchy substances.   
The large solvent demand for ammunition production during the two world wars and the 
simultaneous rapid expansion of the auto industry drove ABE fermentation to become the second 
largest fermentation process next only to ethanol fermentation12. However, the ABE fermentation 
declined drastically in the 1950s owing largely to the blooming of the petrochemical industry, and 
its quick loss of market share was further exacerbated by the escalating price of fermentation feed 
materials12. Though certain small scale ABE fermentation plants continued in some specific 
markets, notably South Africa, until early 1980s, the large scale production had ceased in Europe 
and the US by 19602.  In the past two decades, the concerns over greenhouse gas emission and the 
sustainability of energy supply have rejuvenated the interest in ABE fermentation. In fact, several 
new ABE fermentation plants are being constructed or have started operation in China in the past 
few years13.   
 
 
2.4. ABE Fermentation   
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ABE fermentation was only found naturally in certain species of the Clostridium genus. All these 
Gram-positive species are strictly anaerobic and capable of forming endospores.  Among them C. 
acetobutylicum is of the most industrial interest and, consequently, best studied2. In addition to C. 
acetobutylicum, Clostridium beijerinckii is another important ABE organism and garnered 
significant engineering efforts1,14. The genomes for both organisms have been completely 
sequenced15,16.  
The typical ABE fermentation is a biphasic process. In the first acidogenesis stage, bacterial cells 
grow rapidly and the acetyl-coA generated through the Embden-Mayhof-Pathway (EMP) was 
predominantly used to produce acetate and butyrate so as to maximize the ATP yield via acetate 
kinase (Ack) and butyrate kinase (Buk)17. The rapid production and secretion of organic acid 
necessarily leads to the decrease of pH, and the resulting low pH, typically between 4.5 and 5.0 
for most strains, is considered a key event triggering the second stage, namely the solventogenesis 
phase18–20. The solventogenesis phase is generally viewed as an adaptive detoxification mechanism, 
in which the butyrate and acetate secreted in the first stage was retaken by the cells and converted 
to butanol and ethanol, respectively, causing an increase in the environmental pH21. Acetone is 
also generated by the cells concomitant with the alcohol production.  
The transition from acidogenesis to solventogenesis is clearly of key industrial relevance and has 
been extensively studied. Apart from the aforementioned decrease in pH, several other interplaying 
factors have been demonstrated to be critical in triggering this physiological change, and these 
factors include the organic acid concentration, bacterial cell density and nutrition limitation2,9. 
Sporulation, though often coincides with C. acetobutylicum entering the solventogenesis phase in 
a batch culture, is not a prerequisite for this transition22,23.  
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2.4.1 The Biochemistry of ABE Fermentation 
The overall biochemical pathways underlying C. acetobutylicum biphasic ABE fermentation are 
shown in Figure 1.2.1. Acetyl-CoA is the starting point of the ABE fermentation. Acetyl-CoA can 
be hydrolyzed to acetate via acetyl-phosphate, with the bond-breaking energy captured by ADP to 
form ATP. Acetyl-CoA can also be chain-elongated to form butyryl-CoA via a sequence of 
reactions that essentially achieves the reversal of -oxidation. To do so, two acetyl-CoA molecules 
are first condensed to form acetoacetyl-CoA catalyzed by thiolase (Thl).  Acetoacetyl-CoA is then 
reduced and dehydrated to form crotonyl-CoA.  Cronotyl-CoA is subsequently reduced to butyryl-
CoA via butyryl-CoA dehydrogenase/electron transferring flavoprotein (Bcd/Etf) complex. This 
enzyme complex from other Clostridium species (C. kluyveri and C. tetanomorphum) has been 
shown to perform an electron bifurcation reaction24. In this reaction, the exergonic reduction of 
crotonyl-CoA by NADH is coupled with the endergonic reduction of oxidized ferredoxin to 
maximize energy utilization. Although Bcd/Etf in C. acetobutylicum has not been characterized, 
it is presumed to perform the same reaction. Butyryl-CoA can then be converted to either butyric 
acid to generate ATP, or reduced to generate n-butanol. 
In the acidogenic phase, acetyl-CoA and butyryl-CoA are converted to acetate and buryrate, 
respectively, which are re-assimilated in the solvenotogic phase. The enzyme at the center of acid 
re-assimilation and solvent production is acetoacetyl-CoA:acyl-CoA transferase (CtfAB), which 
catalyzes the transfer of the CoA group from acetoacetyl-CoA to butyrate or acetate25. 
Acetoacetyl-CoA after losing its CoA group further undergoes a decarboxylation step releasing 
CO2 while producing acetone. As CO2 is released into the gas phase, this decarboxylation step 
provides the driving force for CoA transfer21. The acetone production also reduces the acetoacetyl-
CoA pool size, providing a driving force to pull down acetyl-CoA towards the condensation 
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direction. Butyryl-CoA and acetyl-CoA generated as products from CtfAB then undergoes two 
steps of reduction catalyzed by a bifunctional aldehyde/alcohol dehydrogenase, AdhE2, leading to 
butanol and ethanol, respectively. In C. acetylbutyricum, AdhE2 is relatively promiscuous with 
regard to its substrates, as it is responsible for both butanol and ethanol production26,27. 
As acetone is the least attractive product in the ABE fermentation, many efforts have been made 
to engineer the bacterial cells to produce butanol with minimal or no acetone. This goal has been 
achieved both in C. acetobutylicum natively and in many foreign hosts. However, all these 
successful cases rely on the direct n-butanol synthesis from acetyl-CoA, a process that will be 
discussed later in this chapter, and not via the native acid re-assimilation.  
The electron distribution of C. acetobutylicum ABE fermentation has also received extensive study. 
C. acetobutylicum uses pyruvate: ferredoxin oxireductase28, Pfor to convert pyruvate, the end 
product of glycolysis, to acetyl-CoA. The reduced ferredoxin can be re-oxidized either by 
hydrogenase, HydA29, to produce molecular hydrogen or via ferredoxin: NAD(P)+ oxidoreductase, 
Fnor30–32, to generate NADH or NADPH.  In the acidogenesis phase, the hydrogenase activity is 
high and the cell produces hydrogen at a high rate. The transition into solventogensis requires more 
NADH for the reduction of acid to alcohol, and, as a result, hydrogenase activity is suppressed and 
Fnor becomes the preferred route33. Incidentally, for C. acetobutylicum Fnor is believed to be a 
critical way for the organism to produce NADPH, as the organism lacks glucose-6-phosphate 
dehydrogenase in the pentose phosphate pathway, as well as nfnAB, a bifurcating enzyme 
prevalently found in many Clostridiaceae capable of generating NADPH from NADH and reduced 
ferredoxin2,24,34. 
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2.4.2 Developing genetics tools in Clostridium acetobutylicum 
Early engineering attempts for strain improvement rely largely on random mutagenesis and the 
subsequent screening for desired phenotypes. Interestingly, one early investigation revealed that, 
for C. acetobutylicum, mutations can be readily generated by direct mutagens including ethyl 
methanesulfonate and N-methyl-N’nitro-N-nitrosoguanidine, but not by indirect mutagens such as 
UV radiation and mitomycin C35. The transformation protocol for C. acetobutylicum was 
established in the late 1980s36, which enables the first reported recombinant C. acetobutylicum in 
199237. The difficulty in transformation encountered in the early days was overcome by in vivo 
methylation38. Multiple shuttle vectors are now readily available, including pMTL80000, which 
modularizes E. coli/C. acetobutylicum cloning39.  
A successful attempt for gene knockout in C. acetobutylicum was first reported in the mid 1990s40. 
This work and many other early reports relied on non-replicating plasmids with single crossover 
into the genome for gene inactivation41. A more streamlined gene inactivation approach that 
allowed the generation of multiple knockouts in C. acetobutylicum strains was reported in 200742 
and optimized in 201043. This system, named ClosTron, is based on a broad host-range Group II 
intron from Lactococcus lactis. The marker removal in the ClosTron system was realized by 
flanking the antibiotic cassette with flippase recognition target (FRT) site, and the subsequent 
flippase-mediated excision enables the reuse of the original marker in the next round of gene 
inactivation. Apart from direct genome editing, gene down regulation via antisense RNA (asRNA) 
has also been demonstrated as a versatile and convenient tool for C. acetobutylicum 
engineering44,45.  In addition to gene knockout, large fragments of genome insertion have also been 
reported in C. acetobutylicum46. The establishment of stable vectors, reliable gene knockout 
protocols, and multiple gene overexpression or repression methods in the past 10-20 years has 
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enabled the research community to engineer Clostridium species with desirable traits for butanol 
fermentation. 
 
2.4.3 Metabolic engineering of Clostridium acetobutylicum for Butanol fermentation 
ABE fermentation using C. acetobutylicum faces several limitations: (1) the fermentation product 
is a mixture of organic compounds with considerable differences in their market values; (2) n-
butanol, the most valuable product also is the most toxic to the bacterial cells which generally 
limited the n-butanol titer below 2% in a batch culture; (3) the ABE fermentation occurs only at a 
certain growth phase of C. acetobutylicum and usually stopped by the subsequent sporulation.  
Enhancing n-butanol production via the inactivation of by-product (acetate, butyrate, ethanol and 
acetone) formation pathways has proven difficult in Clostridium acetobutylicum. For instance, 
knocking out acetone biosynthesis pathway alone will only lead to the accumulation of acid 
products and not butanol47,48, presumably because of the loss of driving force discussed above. 
Furthermore, it is clear that our current understanding of C. acetobutylicum metabolic network is 
not a complete one, as knocking out key enzymes in the acetate pathway (Pta or Ack) doesn’t lead 
to an acetate negative phenotype41. The similar phenomenon was also observed in butyrate 
pathway inactivation. The most fruitful strategy so far appears to be directly enhancing acetyl-
CoA to butanol pathway through enzyme overexpression, e.g. Thl or AdhE2, while simultaneously 
reducing acid production by knocking out genes participating in acetate or butyrate pathway49. 
n-Butanol toxicity has long been recognized to be a major limiting factor in ABE fermentation, as 
the other two fermentation products, acetone and ethanol, are much less toxic and generally do not 
accumulate to the toxicity level during fermentation2. The mechanism behind n-butanol toxicity is 
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complicated, but the cell membrane is generally viewed as the most direct target. It has been 
hyphothesized that n-butanol can insert into the membrane lipid layer to increase membrane 
fluidity thus negatively impacting intracellular pH maintenance and ATP generation capacity50. 
Supporting this hypothesis, C. acetobutylicum cells have been observed to significantly increase 
saturated lipid proportion in the membrane in response to n-butanol exposure to compensate for 
the increase in membrane fluidity51. Interestingly, successful engineering efforts through rational 
design to boost n-butanol tolerance so far did not come from directly modifying lipid synthesis. 
Overexpression of Class I stress-response operon groESL, which is known for cellular protein 
stabilization, confers over 30% increase in n-butanol tolerance in C. acetobutylicum52. Another 
group reported the implementation of glutathione biosynthesis pathway into C. acetobutylicum, 
which increases the overall robustness of the production strain including n-butanol tolerance, and 
the resulting C. acetobutylicum is reported to reach an n-butanol titer of 15g/L53. 
The appeal for an asporogenous C. acetobutylicum strain to industrial solvent production is quite 
obvious: as sporulation normally occurs as the bacteria enter the solventogenesis phase, it imposes 
a limited time window during which n-butanol production can proceed. Interestingly, sporulation 
and solventogensis have unexpected genetic association. Early continuous culture attempts for C. 
acetobutylicum solvent production often observe the bacterial degeneration, in which the cells 
simultaneously lose the sporulation and soventogenesis phenotype54. It was later revealed that 
several essentially genes for both phenotypes were located on the C. acetobutylicum megaplasmid 
pSOL1, and the loss of this plasmid ultimately resulted in the strain degeneration55. One early 
engineering effort used antisense RNA (asRNA) to downregulate key sporulation factor SpoIIE in 
C. actobutylicum and successfully delayed the sporulation process22. Although, in this work, the 
delay in sporulation did not lead to a significant increase in solvent production as one might have 
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anticipated, the result from this study showed that these two phenotypes, sporulation and solvent 
production, can indeed be uncoupled. A more recent study started its engineering effort from a C. 
acetobutylicum strain M5 lacking the pSOL1 megaplasmid, hence the asporogenous and 
nonsolvent production phenotype, and attempted to reengineer back the n-butanol production 
capacity56. By overexpressing key enzymes in the n-butanol pathway, most notably, Thl, the 
authors managed to restore n-butanol titer to the wild type level. However, the lack of acetone 
pathway, also on pSOL1, abolished the acid re-assimilation capacity of the bacteria leading to a 
considerable accumulation of acid byproduct. Evidently there is still room for further strain 
improvement.   
 
 
2.5. n-Butanol Production in Non-native Producers 
 
2.5.1 Rationale for using non-native producers 
With the increase in understanding of the n-butanol pathway, efforts in the past 10 years have 
begun to implement n-butanol production in non-native producers, including E. coli57,58, 
Synechococcus elongates59, Saccharomyces cerevisiae60, Pseudomonas putida61, Bacillus 
subtilis61, Thermoanaerobacterium saccharolyticum62, Lactobacillus brevis63, and Clostridium 
tyrobutyricum64. Despite technical challenges, including difficulty in gene expression, oxygen-
sensitivity of key enzymes, and host cofactor preference, n-butanol production using foreign hosts 
bear several advantages. These benefits include: (1) genetic tools and knowledge are much better 
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developed in model microorganisms such as E.coli, S. cerevisiae, and B. subtilis in comparison 
with C. acetobutylicum; (2) using foreign hosts circumvents many C. acetobutylicum traits that are 
hostile to industrial fermentation, such as sporulation, low growth rate, and low cell density, and 
strict requirement for anaerobic conditions9; (3) the adoption of a foreign host opens the door for 
the integration of n-butanol production with the desirable physiology of the host. A keen example 
is the implementation of n-butanol pathway in cyanobacteria S. elongates PCC7942: the 
photosynthetic capacity of the cyanobacteria allows direct n-butanol production from CO2
59. 
 
2.5.2 Pathways for n-butanol biosynthesis 
n-Butanol has been synthesized in various organisms with different pathways.  The CoA-
dependent pathway from Clostridium and its variations (Fig. 2.1) is the best studied65.   This 
pathway is chemically similar to the reversal of β-oxidization66,67. The intrinsic iteration nature of 
reverse β-oxidization also enables the biosynthesis of longer chain alcohols, e.g. n-hexanol and n-
octonol66.  The citramalate pathway and threonine pathway fall into the same broad group as the 
keto-acid pathway (Fig. 2.2), which is more commonly utilized for isobutanol production.  
Within the CoA-dependent pathway, the most difficult step towards n-butanol production in a 
foreign host was the reduction from cronyl-CoA to butyryl-CoA. This step was catalyzed natively 
in C. acetybutyricum by the enzyme complex Bcd/Etf, which is oxygen sensitive and requires 
ferredoxin as an additional redox partner68; both factors hamper the enzyme activity in 
heterogeneous hosts. This initial technical difficulty was overcome by substituting Bcd/Etf with 
trans-enyol-CoA reductase (Ter), an enzyme readily expressed in E. coli and only requires NADH 
as the source of electron69,70.   
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Figure 2.1. CoA-dependent n-butanol biosynthesis pathways in C. acetobutylicum (ABE 
fermentation) and its variations. The non-native enzymes were marked with underscores for 
differentiation. Enzyme abbreviations: Pfor, pyruvate:ferredoxin oxireductase; HydA, 
hydrogenase; Fnor, ferredoxin:NAD(P)+ oxireductase; Pta, phosphotransacetylase; Ack, acetate 
kinase; AdhE2; aldehyde/alcohol dehydrogenase; Thl, thiolase; Hbd, hydroxybutyryl-CoA 
dehydrogenase; Crt, crotonase; Bcd/Etf, butyryl-CoA dehydrogenase/ electron transferring 
flavoprotein complex; Ptb, phosphotransbutylase; Bk, butyrate kinase; CtfAB, acetoacetyl-
CoA:acyl-CoA transferase; Aadc, acetoacetyl-CoA decarboxylase; Acc, acetyl-CoA carboxylase; 
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AtoB, acetyl-CoA acetyltransferase; PhaA, acetoacetyl-CoA thiolase/synthase; Ter, trans-enyol-
CoA reductase. 
 
In addition to Bcd/Etf, the aldehyde/alcohol dehydrogenase AdhE2 is the second enzyme in the 
native n-butanol pathway that is sensitive to oxygen. This oxygen sensitivity is particularly 
problematic when implementing the pathway in a photosynthetic organism like S. elongates, where 
oxygen is produced concomitant with carbon fixation71. Through bioprospecting and subsequent 
screening, two oxygen-tolerant dehydrogenases (PduP from Salmonella enterica and YqhD from 
E.coli) were used to substitute AdhE2 (Fig. 2.1). The key enzyme PduP, annotated as CoA-
acylating propionaldehyde dehydrogenase, was found to catalyze the reduction of a broad range 
of acyl-CoAs to their corresponding aldehydes71. As a result for this enzyme substitution, n-
butanol production titer in S. elongatus PCC 7942 was reported at 404 mg/L, exceeding the base 
strain by 20 fold71. 
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Figure 2. The keto acid pathways for the production of n-butanol, isobutanol, and related 
compounds. Enzyme abbreviations: Pyk, pyruvate kinase; Ppc, phosphoenolpyruvate carboxylase; 
AspC, aspartate aminotransferase; ThrA, apartate kinase/homoserine dehydrogenase; asd, 
aspartate semialdehyde dehydrogenase; ThrB, homoserine kinase; ThrC, threonine synthase; 
LeuA, 2-isopropylmalate synthase; LeuCD, 2-isopropylmalate hydrolyase/3-isopropylmalate 
hydrolyase; LeuB, 3-isopropylmalate dehydrogenase; IlvA, threonine deaminase; AlsS/IlvBN, 
acetolactate synthase; IlvC, 2-aceto-2-hyroxy-butyrate:NADPH+ oxidoreductase; IlvD, 2,3-
dihydroxy-2-methylvalerate hydrolyase; CimA, citramalate; Kivd, α-ketoisovalerate 
decarboxylase; AdhE2, aldehyde/alcohol dehydrogenase; kor, ketoisovalerate oxidoreductase; 
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aldh, aldehyde dehydrogenase. Metabolite abbreviations: glu, glutamate; αKG, α-ketoglutarate. 
 
Another major bottleneck in n-butanol CoA-dependent pathway is the condensation reaction 
between two acetyl-CoA to form one acetoacetyl-CoA. This reaction is thermodynamically 
unfavorable with a calculated ΔGo’ of 27.4kJ/mol72,73. In addition to bioprospecting and screening 
strong enzymes to help catalyze this key step of reaction, e.g. using AtoB from E. coli57 and PhaA 
from Ralstonia eutropha70, a different strategy to surmount the energy barrier is by coupling the 
reaction with ATP expenditure72. This concept was demonstrated experimentally by re-routing the 
reaction through the ATP-dependent acetyl-CoA carboxylation to formmalonyl-CoA using 
Acetyl-CoA carboxylase (Acc), followed by condensation with the second acetyl-CoA in a 
decarboxylative step to form acetoacetyl-CoA72 (Fig. 1.2.1). The overall ΔG’ of the new two-step 
conversion is now -13.8kJ/mol72. The implementation of this strategy in cyanobacteria S. elongates 
PCC7 942 enables improved n-butanol production using CO2 as the direct carbon source.  
 
2.5.3 Improve n-butanol production with driving forces 
The first few successful implementations of n-butanol pathway in foreign hosts reported titers 
generally below 1 g/L. Since then many efforts have been made for improvement. These efforts 
can occur at the enzyme level as mentioned in the previous section via bioprospecting, screening 
or protein engineering. Using enzymes with increased oxygen-tolerance, preferred cofactor or 
better kinetics in the key pathway steps have been fruitful and led to better n-butanol titer and 
productivity. One can also rewire part of the pathway, as in the case of changing single step 
acetoacetyl-CoA formation into two steps with ATP activation and malony-CoA as an 
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intermediate, to overcome the energy barrier of one-step reaction72. However, so far, one of the 
highest n-butanol titers reported in a foreign host is achieved by implementing cofactor recycling 
as a driving force, essentially making n-butanol production obligatory for the host bacteria 
anaerobic growth and CoA regeneration69.  In this report, Shen and coworkers observed that 
almost all successful fermentation pathways with product titer above the toxicity level involve a 
driving force in the forms of (1) release of gaseous molecule, (2) irreversible reaction or 
polymerization; (3) ATP expenditure or synthesis; (4) electron transfer to external sink; or (5) 
product removal via phase separation69. Consequently, the authors attributed the traditionally low 
n-butanol production from CoA-dependent pathway to the lack of such a driving force. In order 
to remedy this disadvantage, all major E. coli native NADH-draining pathways, including 
ethanol, lactate and succinate biosynthesis, were knocked out. The resulting strain, unable to 
regenerate NAD+ for glycolysis, lost its ability to grow anaerobically. The subsequent 
implementation of NADH-consuming n-butanol pathway with Ter substituting Bcd/Etf re-
enables the cells to grow anaerobically with the obligatory production of n-butanol. Furthermore, 
the knockout of Pta (phosphate acetyltransferase) makes the acetyl-CoA condensation to 
acetoacetyl-CoA in the n-butanol pathway the only step for CoA regeneration from acetyl-CoA. 
Combining these two driving forces, i.e. NADH and CoA recycling, resulted an n-butanol titer of 
15g/L (30g/L with in situ product removal)69. 
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2.6. Isobutanol Production   
The formation of isobutanol from amino acid in yeast was first described by Ehrlic in 1907 as one 
of the  fusel alcohols produced from amino acids74,75. Since then, the generation of these fusel 
alcohols has been studied in the context of controlling (off-) flavor in yeast fermentation.   The 
initial investigation of isobutanol production focused on how isobutanol was produced from the 
deamination of valine with isobutanol production at the ppm level76. However, since isobutanol 
was natively produced from amino acid in small quantities, it was not considered as a viable fuel. 
The concept that this compound could be produced in large enough quantity from sugar to serve 
as a fuel was proposed and demonstrated only in the past decade77. Compared to n-butanol, 
isobutanol is a very recent addition to the mix of biofuels produced by microorganisms. Despite 
its short history, it is already been in industrial production. Isobutanol production is based on the-
keto acid pathway (Fig. 1.2.2)77. The relative amenability of this pathway for engineering 
compared to the n-butanol pathway was demonstrated in E. coli, which was able to achieve a titer 
of 22 g/L of isobutanol and 86% of the maximum theoretical yield in the first report77. -
Ketoisovalerate, which is the -keto acid precursor of isobutanol, is also an intermediate in the 
biosynthesis of valine, and thus the pathway is transferable to many other microorganisms. The 
valine pathway starts with pyruvate and extends the chain length by two to -ketoisovalerate. 
Instead of being transaminated into valine, -ketoisovalerate is then decarboxylated by -
ketoisovalerate decarboxylase to isobutyraldehyde, which is then reduced by an alcohol 
dehydrogenase to form isobutanol. 
 
 2.6.1 The Biochemistry of Isobutanol Production  
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The term -keto acids refers to carboxylic acids with a keto group adjacent to the carboxylic group. 
The conversion of -keto acids to alcohols is the basis of industrial ethanol production, where 
pyruvate decarboxylation followed by reduction is the most efficient path for ethanol production. 
Instead of direct decarboxylation, pyruvate can be chain-elongated to longer -keto acids. The 
chain elongation can be accomplished using two sets of enzymes (Fig. 1.2.2), one used in valine 
and isoleucine biosynthesis, there other used in leucine synthesis. The former increases the chain 
length by two and introduces a carbon branch, and is used in isobutanol production77.  The latter 
linearly increases the chain length by one, and is used in n-butanol production through 
ketovalerate78,79  
The valine/isoleucine pathway (Fig. 1.2.2) starts with the formation of acetolactate from two 
pyruvate, catalyzed by acetohydroxy acid synthase (AHAS). The reaction proceeds by the 
decarboxylation of pyruvate followed by the transfer of acetaldehyde to the second molecule of 
pyruvate80,81.  AHAS enzymes are generally highly regulated by feedback inhibition from 
branched chain amino acids. The production of isobutanol is most successful when using a 
catabolic acetolactate synthese (AlsS) from Bacillus subtilis77, which is highly active and not 
regulated. The second step of valine biosynthesis involves acetohydroxy acid isomeroreductase 
which reduces and isomerizes -acetolactate into (2R)-2,3-dihydroxy-3methylbutanoate82. The 
subsequent dehydratation of (2R)-2,3-dihydroxy-3methylbutanoate by dihydroxy acid dehydratase 
forms -ketoisovalerate83. Dihydroxy-acid dehydratase (ilvD) is the penultimate step in the valine 
biosynthesis pathway. From this point, -ketoisovalerate can be aminated by transaminase to form 
valine or continue with leucine biosynthesis or in this case, the production of isobutanol. 
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The decarboxylation step in isobutanol production has been studied in yeast for the understanding 
of valine catabolism in S. cerevisiae76. With 13C-labeling studies and different knock-out strains in 
yeast, pyruvate decarboxylase was identified to be responsible for the decarboxylation of -
ketoisovalerate76. However, the -ketoisovalerate decarboxylation activity for  pyruvate 
decarboxylase was too low to effect high-flux isobutanol production. In contrast, -ketoisovalerate 
decarboxylase (encoded by kivd) from Lactococcus lactis84 was shown to be highly effective77. 
Kivd, as well as pyrvuate decarboxylase, belong to a group of thiamin pyrophosphate-dependent 
-keto acid decarboxylase, which catalyze the decarboxylation of a -keto acid of into an aldehyde. 
In the case of kivd, -ketoisovalerate is converted into isobutyraldehyde with a loss of carbon 
dioxide. Following the decarboxylation of -ketoisovalerate, isobutyraldehyde is then reduced to 
isobutanol by alcohol dehydrogenase.  
 
2.6.2 Isobutanol production from sugar 
Atsumi, et al.77 first overexpressed ilvI ilvH ilvC and ilvD from E. coli under the control of the 
pLlacO1 promoter along with kivd and ADH2 on another plasmid. With the overexpression of the 
valine biosynthesis pathway, the authors were able to produce isobutanol up to 1.7g/L. To improve 
the titer, they knocked out the competing pathways and regulators in E. coli, including adhE, ldhA, 
frdAB, fnr and pta for the conservation of pyruvate and reducing power NADH. They further 
overexpressed AlsS from Bacillus subtilis, which is a catabolic enzyme performing the same 
reaction as IlvIH but with a higher affinity toward pyruvate. Putting together all the strategies, they 
achieved a final titer of 22g/L isobutanol after 24 hours under micro-aerobic conditions.77 
Interestingly, most of the isobutanol was produced after the cells have entered the stationary phase.  
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This ability allows the cells to produce to a titer much higher than the toxicity level measured by 
growth. 
Atsumi, et al. 85 found that the acetolactate synthase (AlsS) from B. subtilis also catalyzed the 
decarboxylation of -ketoisovalerate as kivd did, rendering the isobutanol pathway kivd-
independent. They also found that the decarboxylase activity of AlsS was deteriorated by the point 
mutation of Q487 of the enzyme but the synthase activity remained almost the same85. In addition, 
Atsumi, et al.86 identified that a large portion of Adh2 previously employed in isobutanol 
production was insoluble when expressed in E. coli and the isobutyraldehyde dehydrogenase 
activities shown in previous studies was due to the native E. coli yqhD activities. The deletion of 
native yqhD decreased isobutanol production by 80%. They further tested one other NADH-
dependent alcohol dehydrogenase (adhA) from L. lactis and found that adhA showed the highest 
activities towards isobutyraldehyde among the three86.  
In addition to the above rational design approach for isobutanol production, an evolutionary 
strategy to increase flux in the valine biosynthesis pathway was developed by feeding the valine 
analogue norvaline 87. By random mutagenesis on a strain harboring the isobutanol pathway and 
selection on plates containing norvaline, several mutants were found to resist norvaline because of 
their increased valine production flux.  Specifically, a strain with improved 24-hour isobutanol 
productivity (8.0g/L) compared to the parental strain (5.3g/L) was isolated87. A final titer of 21.2 
g/L was achieved after repairing the rpoS gene damaged in evolution. A higher titer at 50g/L was 
further achieved in 1-L scale bioreactor by in situ removal of isobutanol through gas stripping88.  
With the successful development of an isobutanol production pathway in E. coli, the -keto-acid 
isobutanol production pathway was transferred to the traditional amino acid producer, 
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Corynebacterium glutamicum 89. The native ilvCD and adhA genes were overexpressed, which led 
to 2.6g/L of isobutanol production with other alcohols as byproducts. Deleting the competing 
pathways, pyruvate carboxylase and lactate dehydrogenase, isobutanol production was increased 
to 4.9g/L. The work showed the potential of both the universality of the -keto-acid isobutanol 
production pathway and the potential of utilization of C. glutamicum for higher chain alcohol 
production89.   
The isobutanaol pathway has also been engineered into the bioethanol producer, S. cerevisiae, with 
the overexpression of the same kivd and the native valine biosynthesis pathway, Ilv2p, Ilv5p and 
Ilv3p in the cytosol90 91. Some efforts focused on overexpression of the Ehrlich pathway and the 
deletion of competing pathways92 93. Others tried to offset the cofactor imbalance by implementing 
a transhydrogenase-like shunt which transfer reducing power from NADH to NAD(P)+ 93. A higher 
titer (635mg/L in complete media94) of isobutanol production in S. cerevisiae was shown by 
Avalos, et al. when the production pathway was compartmentalized in the mitochondria of the cell 
leading to a higher concentration of both the enzymes in the pathway and the important 
intermediate, -ketoisovalerate94. 
 
2.6.3 Isobutanol Production from Cellulose 
Direct conversion of cellulose to biofuels is expected to save the overall production cost.    
Higashide, et al.95 overexpressed the isobutanol production pathway in Clostridium cellulolyticum 
under the control of the constitutive ferredoxin (Fd) promoter from Clostridium pasterianum. 
Unfortunately, the full-length AlsS was toxic to the strain. Interestingly, a single nucleotide 
mutation in alsS resulting in a stop codon in the middle of the sequence produced a shorter, but 
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non-toxic AlsS in C. cellulolyticum. With the truncated protein, they were able to achieve the titer 
of 660mg/L of isobutanol produced from cellulose95.  
The direct conversion of cellulose to biofuels would be more favorable under high temperatures 
to favor cellulose hydrolysis and reduce the chance of contamination.  Lin, et al. 96, was successful 
in production of isobutanol using the cellulytic thermophile, Clostridium thermocellum.  They also 
confirmed that an alternative pathway to kivd exists in this organism: a ferrodoxin-dependent 
oxidoreductase which decarboxylases -ketoisovalerate to produce isobutyl-CoA and then 
reduced to isobutanol. Their best result showed a titer of 5.4g/L of isobutanol from cellulose at 
50oC within 75 hours and at 41% of theoretical yield96.  
In addition to cellulose, cellobionic acid is another carbon feedstock that is commonly found in 
lignocellulose hydrolysate. Desai, et al. 97 demonstrated that cellobionic acid could be used as a 
sole carbon source for growth and isobutanol production in E. coli. They were able to produce 
2.7g/L of isobutanol from 10.4g/L of commercial cellobionic acid97.  
 
2.6.4 Isobutanol Production from CO2 
The isobutanol pathway was also transferred to a photosynthetic microorganism98, Synechococcus 
elongatus PCC7942 with kivd integrated into the neutral site NSI and alsS, ilvCD into the neutral 
site NSII for production of the isobutanol precursor, isobutyraldehyde. Since isobutyraldehyde is 
a volatile compound, a gas stripping method was used to remove the product from the culture and 
to trap it in a Graham condenser separated from the culture. A final titer of 723 mg/L at a 
productivity of 2.5 mg/L/hr over 12 days was achieved 98.  Overexpression of the rbcLS genes 
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coding for the Rubisco large and small subunits raised the isobutyraldehyde production to 1.1g/L 
at the rate of 6230ug/L/h over 8 days. Finally, isobutanol production was demonstrated by 
integrating three different alcohol dehydrogenases downstream of the kivd .The strain with the 
NADPH-dependent yqhD and kivd overexpression showed 450 mg/L isobutanol overexpression 
in 6 days98.  
In addition, isobutanol production from carbon dioxide using inorganic electron donors have also 
been demonstrated in a lithoautotrophic microorganism, Ralstonia eutropha99. R. eutropha has 
been used a production host for polyhydroxybutyrate. This organism can use either molecular 
hydrogen or formic acid as an electron donor for CO2 fixation. With the development of an 
anhydrotetracycline-inducible gene expression system in the microorganism, 100 isobutanol and 3-
methylbutanol were produced over 1.4 g/L from CO2 using R. eutropha 
99.  To drive this process 
with electricity, a consolidated electro-microbial system was established, where the 
electrochemical production of hydrogen and formate occurred concurrently with microbial 
production of biofuel. The simultaneous production of formate and uptake by the R. eutropha 
diminishes the product inhibition at the electrode and thus raises the efficiency of the electrolytic 
process99.  
 
2.6.5 Isobutanol Production from waste protein 
In the most cases, waste protein from agriculture our industrial sources has not been utilized 
efficiently. Since the keto acid pathway is closely related to amino acids, the latter can be 
deaminated to become keto acids to produce various fuels and chemicals. Huo, et al. 101developed 
an E. coli strain to use protein hydrolysate as the feedstock for the production of keto acid-derived 
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biofuels. Although amino acids are commonly used in the growth media, their efficient degradation 
by microbes is challenging. Several strategies were used to increase the production of isobutanol 
and other fuels from amino acids, including the deletion of quorum sensing genes luxS or lsrA. To 
better utilize the carbon skeleton on the amino acids, three transamination cycles were devised for 
the deamination of amino acids, and released the respective -keto acids, such as -
ketoglutarate, -keto methylvalerate, -keto isocaproate and pyruvate. Furthermore, the 
ammonium-assimilation genes, gdhA and glnA were deleted so that ammonim was irreversibly 
produced. With the above metabolic engineering strategies, C4 and C5 alcohols were accumulated 
to 4g/L from 21.6g/L hydrolyzed protein, which is 50-70% of what could be produced from the 
same amount of yeast extract.101 
Choi, et al. 102consolidated the above process of proteolysis and biofuel production using B. subtilis 
which is capable of secreting proteases into its growth medium, eliminating the need for adding 
protease for protein hydrolysis. They inactivated the branched-chain amino-acid global regulator 
codY and deleted the lipoamide acyltransferase (bkdB) to prevent converting branched-chain -
keto acids into acyl-CoA products. By overexpressing leuDH, kivD and yqhD in the modified 
strains, they were able to produce 1.6 g/L of ammonia and 1.1g/L of biofuels with carbon chain 
more than or equal to two102.  
Branduardi, et al.103, designed another pathway for butanol production in S. cerevisiae employing 
glycine as one of the carbon sources. They overexpressed glycine oxidase, malate synthase, -
isopropylmalate dehydrogenase, -ketoacid isomerease, pyruvate decarboxylase and alcohol 
dehydrogenase in the strain and with 20g/L of glucose supplemented with glycine, the strain 
produced 92mg/L and 58mg/L of n-butanol and isobutanol, respectively103.  
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2.6.6 Isobutanol Tolerance of E. coli 
Wild-type E. coli cannot grow in the presence of isobutanol concentrations higher than 6 g/L.  
However, E.  coli was able to produce isobutanol up to 22 g/L 77. Apparently, the toxicity to growth 
did not limit the production. The cells continued to produce even after they ceased to grow.  As 
such, toxicity to production does not correlate with the toxicity to growth.  However, most studies 
of toxicity have focused on growth. 
Atsumi, et al.104 used serial dilutions of E. coli strain in LB medium containing increasing 
concentration of isobutanol to adapt the culture.  A mutant that could grow in the presence of 8 
g/L of isobutanol was isolated.  After genome sequencing, 25 insertional sequences elements 
were found in the chromosome, and one large fragment of DNA containing 62 genes were 
deleted. By systematically reconstructing these gene knockouts in the parental strain, five gene 
knockouts (arcA, gatY, tnaA, yhbJ and marCRAB) were identified to be the most important104 . 
Among them, arcA and marC are transporters possibly involved in pumping out isobutanol. 
Others do not have immediately obvious effect. Importantly, the isobutanol-tolerent strain did 
not show increased isobutanol production, as expected.  Minty et al. 105 used a similar approach 
and identified a similar set of the genes, including marC, arcA, and gatY, as responsible for 
isobutanol tolerance. Isobutanol tolerance was also slightly improved by expressing the 
cyclopropane fatty acid synthase (cfa) that altered membrane composition106 , or by randomly 
mutating the global transcription factor cAMP receptor protein (CRP) 107, followed by selection. 
However, none of the strategies demonstrated increased isobutanol production either. 
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2.6.7 Other products from the keto acid pathway 
In addition to isobutanol,  the -keto-acid pathway (Fig. 1.2.2) was used to produce n-butanol and 
1-propanol using E. coli.78 With the same strategy, 2-methyl-1-butanol (Fig. 1.2.2) was produced 
from the threonine biosynthesis pathway and by knocking out competing pathways such as metA, 
ldh, leuABCD, ilvE 108).  In addition, E. coli production of 3-methyl-1-butanol (Fig. 1.2.2) was 
demonstrated using random mutagenesis and selection on 4-aza-D,L-leucine which is a leucine 
analog 109. As a result of the selection, they were able to produce 3-methyl-1-butanol up to 
4.4g/L.108 Furthermore, the keto-acid pathway was extended 79using protein engineering strategies 
to produce even longer chain organic acids and alcohols . Rodriguez, et al. 110 further demonstrated 
the production of isobutyl-acetate, which is an important industrial ester solvent, by the 
overexpression of alcohol O-acyltransferase which esterifies isobutanol and acetyl-CoA. 
 
2.7. Summary and outlook 
ABE fermentation was one of the most successful fermentation operations in the first half of the 
20th century, but was faced out by the strong competition from the petrochemical industry. 
However, with the increasing awareness of global warming resulted from unchecked usage of 
fossil fuels, there is a revived interest in butanol production via biological routes. This interest in 
biofuel coupled with the rapid development of metabolic engineering saw a slew of ground 
breaking reports in butanol fermentation in the past 10~20 years. Successful efforts have been 
made both to engineer the native producer C. acetobutylicum more amenable to industrial scale 
production, and to efficiently implement n-butanol pathways in non-native producers, such as E. 
coli that has been long used in other fermentation processes. In addition, the newly developed 
39 
 
isobutanol pathway has proved to be at least as promising as n-butanol. It’s amenability to 
engineering allows rapid progress in implementing the isobutanol pathway in multiple organisms.    
Major n-butanol and isobutanol production breakthroughs in the future are likely to come from 
two fronts. The first lies in the significant increase in production titer, yield, and productivity. Due 
to toxicity and other biochemical and physiological limitations, n-butanol and isobutanol 
fermentation rarely achieve a titer above 2.5% without in situ production removal. The low titer in 
turn reduces yield and productivity in most processes.  The second aspect is the broadening of 
fermentation substrates, particularly to the use olignocellulosic biomass and CO2, which are the 
most abundant renewable carbon sources on earth.  Converting these renewable substrates to n-
butanol and isobutanol at high titers, yields, and productivities will be the ultimate goal. 
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Chapter 3. The Reverse Glyoxylate Shunt-1 
 
Disclaimer: Part of this chapter is reprinted from Samuel E. Mainguet, Luisa S. Gronenberg, 
Sio Si Wong, James C. Liao, A reverse glyoxylate shunt to build a non-native route from C4 
to C2 in Escherichia coli. Metabolic Engineering 19, 116-127 (2013) with permission obtained 
from the publisher. 
 
 
3.1. Abstract 
Most central metabolic pathways such as glycolysis, fatty acid synthesis, and the TCA cycle have 
complementary pathways that run in the reverse direction to allow flexible storage and utilization 
of resources. However, the glyoxylate shunt, which allows for the synthesis of four-carbon TCA 
cycle intermediates from acetyl-CoA, has not been found to be reversible to date. As a result, 
acetyl-CoA can only be produced by decarboxylation of the three-carbon molecule pyruvate in 
heterotrophs. A reverse glyoxylate shunt (rGS) could be extended into a pathway that converts C4 
carboxylates into two molecules of acetyl-CoA without loss of CO2.  Here, as a proof of concept, 
we engineered in E. coli such a pathway to convert malate and succinate to oxaloacetate and two 
molecules of acetyl-CoA. We introduced ATP-coupled heterologous enzymes at the 
thermodynamically unfavorable steps to drive the pathway in the desired direction.  This synthetic 
pathway in essence reverses the glyoxylate shunt at the expense of ATP. When integrated with 
central metabolism, this pathway has the potential to increase the carbon yield of acetate and 
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biofuels from many carbon sources in heterotrophic microorganisms, and could be the basis of 
novel carbon fixation cycles.  
 
 
3.2. Introduction 
The tricarboxylic acid (TCA) cycle, in addition to generating energy and reducing power for 
cellular metabolism, provides intermediates that are essential precursors for numerous cellular 
building blocks. With each turn of the TCA cycle, one molecule of acetyl-CoA (C2) is converted 
into free CoA, 2 molecules of CO2, energy in the form of ATP, reducing equivalents in the form 
NAD(P)H, and water. The glyoxylate shunt, first described by Kornberg and Krebs in 19571 avoids 
the two decarboxylation steps of the TCA cycle, therefore allowing acetyl-CoA to be converted to 
TCA cycle intermediates without carbon loss (Fig. 1A, black line). This shunt is the key feature of 
the glyoxylate cycle, which allows cells to grow on C2 compounds such as acetate or fat-derived 
acetyl-CoA when carbohydrates are limited. The glyoxylate shunt involves two enzymes, isocitrate 
lyase (ICL) and malate synthase (MS), which convert isocitrate and acetyl-CoA to malate and 
succinate. While most cenUse the "Insert Citation" button to add citations to this document. 
Use the "Insert Citation" button to add citations to this document. 
tral metabolic processes such as glycolysis, the TCA cycle, and β-oxidation of fatty acids, have 
counter-processes in the anabolic direction (gluconeogenesis, reductive TCA cycle, and fatty acid 
synthesis, respectively), the glyoxylate shunt has only been found to run in the acetyl-CoA 
assimilating, but not in the acetyl-CoA producing direction. As a result of this irreversibility, 
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acetyl-CoA can only be produced by decarboxylation of the three-carbon molecule pyruvate in 
heterotrophic metabolism of organisms such as E. coli. This limitation creates a major loss of 
carbon in the utilization of carbohydrates for the synthesis of acetyl-CoA, a precursor to alcohols, 
fatty acids, isoprenoids and other useful bioenergy compounds. A synthetic pathway built upon a 
reverse version of the glyoxylate shunt would provide a means of directly splitting a C4 TCA 
intermediate into two acetyl-CoA molecules (Figure 1). Since no reverse glyoxylate shunt (rGS) 
is known in nature, we examined how a synthetic rGS could be built in E. coli (Fig. 1, glue, green, 
purple). We extended the reverse shunt by introducing additional steps to convert isocitrate into 
acetyl-CoA and oxaloacetate (OAA) (Fig. 1), thereby constructing a pathway that allows for 
conversion of two C4 molecules into one C4 and two C2 molecules. We used genetic tests to 
determine activity of individual steps in the pathway as well as the combined activity of the 
pathway from malate and succinate to oxaloacetate and two acetyl-CoA.   
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Figure 1) The glyoxylate cycle in the context of E. coli central metabolism. The native 
glyoxylate cycle, as described by Kornberg and Krebs, is shown in black. The reverse glyoxylate 
cycle is highlighted in color. ACN and MDH are known to be natively reversible (shown in yellow). 
In vivo reversibility of ICL (purple) is unknown. MS and CS are not easily reversible, but ATP-
driven enzymes can accomplish the reverse reactions. CS = citrate synthase, ACN = aconitase, 
ICL = isocitrate lyase, MS = malate synthase, MDH = malate dehydrogenase, ACL = ATP-citrate 
lyase, MTK = malate thiokinase, MCL = malyl-CoA lyase. 
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3.3. Methods 
 
3.3.1 Strain construction 
All strains used in that study are listed in Table 1. JCL16 (rrnBT14 ΔlacZWJ16 hsdR514 
ΔaraBADAH33 ΔrhaBADLD78/F’ [traD36 proAB+ lacIqZΔM15]) was used as the wild type (WT)2. 
XL-1 Blue (Stratagene) was used to propagate all plasmids. BL-21 DE3 (Invitrogen) was used to 
express enzymes prior to enzyme assays. Gene deletions were carried out by P1 transduction using 
single knockout strains from the Keio collection3. Each knockout was verified by PCR using the 
following primers flanking the deleted locus: gltA (5’-GTTGATGTGCGAAGGCAAATTTAAG-
3'+ 5’-AGGCATATAAAAATCAACCCGCCAT-3’), prpC (5’-
GTATTCGACAGCCGATGCCTGATG-3’ + 5’-CTTTGATCATTGCGGTCAGCACCT-3’), 
mdh (5’- TTCTTGCTTAGCCGAGCTTC-3’ + 5’- GGGCATTAATACGCTGTCGT mqo (5’-
GACTGCTGCCGTCAGGTCAATATG-3’ + 5’-CTCCACCCCGTAGGTTGGATAAGG-3’), 
ppc (5’-ACCTTTGGTGTTACTTGGGGCG-3’ + 5’-TACCGGGATCAACCACAGCGAA-3’), 
aceB (5’- CTATTTCCCGCACAATGATCCGCA-3’ + 5’-
CTTCAATACCCGCTTTCGCCTGTT-3’), citE (5’-GCGACTGAAACGCTATGCCGAA-3’ + 
5’-TTCAGTTCGCCGCTCTGTACCA-3’), icd (5’-GTTTACCCGGCTGGGTTAA-3’ + 5’-
AGTCACGATCGTTAGCAATTG-3’). 
 
3.3.2. Plasmid construction  
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All plasmids used in this study were assembled using isothermal DNA assembly, as described by 
Gibson (2011)4. Briefly, backbone of the plasmid and insert(s), overlapping by 16-20 bp on each 
end, were PCR-amplified using iProof polymerase (Biorad). DNA amplicons of the expected size 
were gel-purified and mixed in equimolar amounts in a final volume of 5 L. 15 L of a reaction 
mix [6.65% PEG-8000, 133 mM Tris–HCl, pH 7.5, 13.3 mM MgCl2, 13.3 mM DTT, 0.27 mM 
each of the four dNTPs, 1.33 mM NAD+, 0.08 U T5 exonuclease (Epicentre), 0.5 U Phusion 
Polymerase (NEB), 80 U Taq DNA ligase (NEB) in water] was added, thoroughly pipet-mixed 
with the DNA, and incubated at 50°C for 1 hour. 5 L of the assembly mixture were transformed 
in Z-competent (Zymo Research) XL1-blue E. coli cells (Agilent) according to manufacturer’s 
recommendations, and plated on LB Agar plates containing the appropriate antibiotic. At least 3 
independent resulting colonies were cultured, their plasmid purified, and verified by sequencing. 
All plasmid used in that study and their features are listed in Table 1. The integral sequences of 
the four plasmids used in the final strain SM178 are shown in Supplementary Information. 
 
3.3.3. Growth Conditions 
For general molecular biology purposes Escherichia coli strains were grown in Luria Bertani (LB) 
medium at 37°C and agitation rates of 200rpm. For strains containing plasmids the medium was 
supplemented with the appropriate antibiotic at the following concentrations: Kanamycin 
50μg/mL, Chloramphenicol 30μg/mL, Ampicillin 50-100μg/mL, Spectinomycin 100μg/mL (all 
antibiotics were purchased from Sigma Aldrich).  
For selections on minimal medium cells were first grown to mid-log phase in LB medium and 
induced with 0.1 mM Isopropyl-β-D-thio-galactoside (IPTG, Gold Biotechnology) for three hours 
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to ensure expression of the proteins of interest. Cells from 1 mL of medium were then harvested 
by centrifugation at 5000 x g and washed once with equal volumes of minimal medium.  The cells 
were resuspended in 1 mL of minimal medium and were inoculated into selective medium to O.D. 
around 0.1. The selective liquid media contained M9 minimal medium, 2% glucose, 1 mM MgSO4, 
0.1 mM CaCl2, 0.1 mg/mL thiamine hydrochloride, 0.1 mM IPTG and the appropriate antibiotics.  
As noted in the text the plates were supplemented with a combination of 10mM aspartate, 10 mM 
glutamate, 10 mM citrate, 10 mM glyoxylate, 10 mM succinate or 10 mM malate (all sodium salts 
from Sigma Aldrich). The Vogel-Bonner medium E was used in the acetyl-CoA auxotroph, 
supplemented by the same amount of malate as stated above.  
 
3.3.4 Enzyme assays 
Isocitrate lyase (ICL) enzyme purification and assay:  
His-tagged E. coli AceA was over-expressed from plasmid pSS25 in E. coli BL21(DE3) cells by 
inoculating LB medium supplemented with spectinomycin 25 mg/L with a 1/100 dilution of an 
overnight culture. Cells were grown at 37°C with agitation rates of 200rpm to mid-log phase and 
induced with 0.1mM IPTG.  The culture was grown for an additional 3 hours under the same 
conditions and cells were then harvested by centrifugation. Cells were lysed in His-binding buffer 
(Zymo Research) by using the bead beater method (TissueLyser II from Qiagen), and were then 
centrifuged to pellet cell debris. Supernatant was applied to a His-Spin Protein Miniprep column 
(Zymo Research) and purified according to manufacturers instructions. Concentration of purified 
protein elute was determined using the BioRad Protein Assay kit, and protein purity was verified 
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by standard SDS-PAGE and Coomassie staining methods. Purified protein was kept on ice and 
used the same day. 
To assay the activity of ICL, the production of isocitrate was coupled to the activity of isocitrate 
dehydrogenase (ICD), which oxidizes and decarboxylates isocitrate to α-ketoglutarate, while 
reducing NADP+ to NADPH. The production of NADPH can be followed spectrophotometrically. 
Reactions were performed at room temperature in UV cuvettes and monitored at 340nm. The 
reaction mixture contained 50mM Tris-HCl, pH 7.5, 100mM NaCl, 5mM MgCl2, 1mM 
dithiothreitol, 5mM NADP+, 0.1X commercial Bacillus subtilis ICD (Sigma Aldrich), and, if 
appropriate, 10mM sodium succinate (Sigma Aldrich) and 10mM sodium glyoxylate (Sigma 
Aldrich) and 18.75μg/mL of purified protein. 
Coupled malate thiokinase (MTK) and malyl-CoA lyase (MCL) enzyme assay. 
Putative native MTK operons placed under the control of the T7 promoter (See supplementary 
methods) were expressed in E. coli BL21(DE3) cells by inoculating LB medium supplemented 
with spectinomycin 25 mg/L with a 1/100 dilution of an overnight culture. Cells were grown at 
37°C with agitation rates of 200rpm to mid-log phase and induced with 0.1mM IPTG. The culture 
was grown for an additional 5 hours at 25°C and cells were then harvested by centrifugation. Cells 
were lysed in 0.1 M Tris-Cl pH 7.5 by using the bead beater method (TissueLyser II from Qiagen) 
and were then centrifuged to pellet cell debris. Concentration of the total soluble protein extract 
was determined using the BioRad Protein Assay kit. Total soluble extracts were kept on ice and 
used the same day. 
MTK activity was tested in a coupled enzyme assay with purified His-tagged MCL (see below). 
MTK performs the ATP-dependent condensation of malate and CoA into malyl-CoA. In turn, 
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MCL cleaves malyl-CoA into acetyl-CoA and glyoxylate, the latter reacting with phenylhydazine 
to form glyoxylate-phenylhydrazone. Formation of glyoxylate-phenylhydrazone is recorded at 324 
nm. Reactions were set up at 37°C in a final volume of 100 L containing 50 mM Tris-Cl pH 7.5, 
5 mM MgCl2, 2 mM phenylhydrazine, 10 mM malate, 2 mM ATP, 0.85 g purified MCL (see 
below), and 0.2-2 g soluble protein extract. Reactions were started by the addition of CoA to a 
final concentration of 1 mM, except for C. auriantacus SmtAB where succinyl-CoA 1 mM was 
used. Specific enzyme activities were calculated based on a glyoxylate standard curve (0-10-20-
30-40 nmoles glyoxylate in 100 L reaction buffer). 
Malyl-CoA Lyase (MCL) enzyme purification: 
His-tagged R. sphaeroides MCL was over-expressed from plasmid pSMg59 in E. coli BL21(DE3) 
cells by inoculating LB medium supplemented with spectinomycin 25 mg/L with a 1/100 dilution 
of an overnight culture. Cells were grown at 37°C with agitation rates of 200rpm to mid-log phase 
and induced with 0.1mM IPTG.  The culture was grown for an additional 3 hours under the same 
conditions and cells were then harvested by centrifugation. Cells were lysed in His-binding buffer 
(Zymo Research) by using the bead beater method (TissueLyser II from Qiagen) and were then 
centrifuged to pellet cell debris. Supernatant was applied to a His-Spin Protein Miniprep column 
(Zymo Research) and purified according to manufacturers instructions. Concentration of purified 
protein elute was determined using the BioRad Protein Assay kit, and protein purity was verified 
by standard SDS-PAGE and Coomassie staining methods. Purified protein was kept on ice and 
used the same day. 
ATP-citrate lyase (ACL) enzyme purification and assay:  
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His-tagged C. tepidum AclBA was over-expressed from plasmid pXL18-4 in E. coli BL21(DE3) 
cells by inoculating LB medium supplemented with spectinomycin 50 mg/L with a 1/100 dilution 
of an overnight culture. Cells were grown at 37°C with agitation rates of 200rpm to mid-log phase 
and induced with 0.1mM IPTG.  The culture was grown for an additional 20 hours at room 
temperature with agitation rates of 200rmp and cells were then harvested by centrifugation. Cells 
were lysed in His-binding buffer (Zymo Research) by using the bead beater method (TissueLyser 
II from Qiagen) and were then centrifuged to pellet cell debris. Supernatant was applied to a His-
Spin Protein Miniprep column (Zymo Research) and purified according to manufacturers 
instructions. Concentration of purified protein elute was determined using the BioRad Protein 
Assay kit, and protein purity was verified by SDS-PAGE. Purified protein was kept frozen at -
80°C in 20% glycerol and used the next day. 
To assay the activity of ACL, the production of oxaloacetate was coupled to the activity of  malate 
dehydrogenase (MDH), which reduces oxaloacetate to malate, while oxidizing NADH to NAD+. 
The consumption of NADH can be followed spectrophotometrically. Reactions were performed at 
room temperature in UV cuvettes and monitored at 340nm. The reaction mixture contained 
100mM Tris-HCl, pH 8.4, 10mM MgCl2, 10mM dithiothreitol, 0.25mM NADH, 3.3U/mL 
commercial porcine heart MDH (Sigma Aldrich), and, if appropriate, 20mM sodium citrate (Sigma 
Aldrich), 0.44mM coenzyme A (Sigma Aldrich), 2.5mM Adenosine triphosphate (ATP) and 
1.283μg/mL of purified protein. 
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3.4. Results  
 
3.4.1. Reversibility of isocitrate lyase    
We developed a genetic selection system to test for reversibility of the glyoxylate shunt enzymes 
in vivo (Fig. 2). The first enzyme of the glyoxylate shunt, ICL is encoded by the E. coli gene aceA.  
The reversibility of ICL was tested based on its ability to convert succinate and glyoxylate to 
isocitrate, which is a precursor for glutamate synthesis. Normally, glutamate is synthesized through 
intermediates of the TCA cycle. By deleting citrate synthase (coded by gltA), E. coli becomes a 
glutamate auxotroph. To avoid a second-site mutation that complements gltA, we also deleted 
prpC, which codes for a proprionate inducible methylcitrate synthase that has minor citrate 
synthase activity5.  The resulting glutamate auxotroph selection strain (gltA prpC) is hereafter 
referred to as the Glu- strain (Fig. 2 and table 1). In the glyoxylate shunt, ICL cleaves isocitrate 
into glyoxylate and succinate.  Therefore, if ICL is active in the reverse, isocitrate-forming, 
direction, the Glu- strain expressing ICL is expected to grow on glucose minimal media 
supplemented with glyoxylate and succinate. As presented in Figure 3A, the strain overexpressing 
Ec AceA using an IPTG-inducible promoter was able to grow in the absence of glutamate when 
both glyoxylate and succinate were supplied in the medium (Strain 2, Fig. 3A). This same strain 
was not able to grow when only glyoxylate or only succinate was added in the medium. A strain 
where AceA was not overexpressed served as a control (Strain 1, Fig. 3A). This strain was not able 
to grow on medium supplemented with both glyoxylate and succinate. These results suggest that 
AceA is reversible in vivo and able to form isocitrate from glyoxylate and succinate. The fact that 
wild-type expression levels of aceA from the chromosome did not allow for growth under these 
59 
 
conditions, is most likely due to the repression of aceA under our growth condition6, which lacks 
the inducer acetate and contains the repressor glucose. The reversibility of E. coli AceA was also 
confirmed in vitro (Fig. 3B). The enzyme was his-tagged and purified, and showed reverse 
(condensing) activity in an enzyme assay, where production of isocitrate was coupled with NADP+ 
reduction by commercial isocitrate dehydrogenase. Formation of NADPH was followed 
spectrophotometrically. Production of isocitrate was also confirmed HPLC analysis by comparison 
to know standards (data not shown).  
 
 
 
Figure 2) Genetic context used for testing reversibility of glyoxylate shunt enzymes. Genes 
prpC and gltA were deleted to construct the glutamate auxotroph strain that was used to test the 
reversibility of the glyoxylate shunt in vivo. Black lines show the native E. coli metabolism leading 
to glutamate biosynthesis. ‘✕’ denotes a gene knockout. Green lines indicate the genes that were 
tested using this design. Open block arrows indicate carbon sources supplied in the growth medium. 
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Figure 3) Reversibility of native glyoxylate shunt enzymes. (A) Versions of Glu- strain 
overexpressing combinations of native MS and ICL genes were tested for their ability to grow on 
glucose minimal medium with the additives indicated beneath each plate. The strains tested 
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expressed the malate transporter Bs dctA and (1) no additional genes; (2) Ec aceA; (3) Ec aceA + 
Ec aceB; (4) Ec aceA + Ec glcB. Images were scanned after 4 days of incubation at 37°C. See 
Table 1 for strains’ detailed genotypes. (B) Enzyme activity of purified AceA was tested in vitro. 
Commercial isocitrate dehydrogenase was used in excess in this coupled assay.  
 
3.4.2. Irreversibility of Malate Synthase  
The enzyme MS acetylates glyoxylate to form malate in the glyoxylate shunt in its native direction. 
Reversal of this reaction is unfavorable (ΔrG’°=44.4 kJ/mol for glyoxylate formation)7. However, 
if reversed, MS would convert malate to acetyl-CoA and glyoxylate. We tested for this reverse 
activity in the Glu- strain overexpressing aceA.  In this strain, any glyoxylate produced from malate 
could act as a substrate for ICL to be condensed with succinate, forming isocitrate and rescuing 
growth. Unfortunately, malate is transported very poorly into E. coli when glucose is present in 
the growth medium8.   
 
To solve the malate transport problem, we first examined the efficiency of this transport step by 
using a ppc strain, which cannot grow in glucose minimal medium unless supplemented with a 
TCA cycle intermediate, such as malate.  Consistent with the previous report9, the ppc strain 
JW39283 cannot grow on minimal medium supplemented by glucose, and it grew poorly when a 
malate supplement was added (Table 2). Overexpression of the E. coli malate transporter dctA did 
not help malate uptake under these conditions (Strain SM43, Table2). However, overexpression 
of the Bacillus subtilis dctA (Bs DctA)10 gene, which is not regulated by glucose in the same way 
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as the E. coli enzyme is, did allow for fast growth of the Δppc mutant on M9 supplemented with 
glucose and malate (Strain SM44, Table 2). 
 
With the malate transport problem solved, we tested the reversibility of MS by using the Glu- strain 
overexpressing malate transporter (Bs DctA) and E. coli MS. Two isoenzymes of MS exist in E. 
coli, and they are coded by aceB and glcB.  No growth on selective plates (malate and succinate 
supplements in glucose minimal medium) was observed when E. coli aceB or glcB were 
overexpressed together with Bs dctA and Ec aceA (Strains 3 and 4, Figure 3A), indicating that, as 
expected, the E. coli MS enzymes are not active enough in the reverse direction to support growth 
in our selection. Interestingly, the growth of strains overexpressing the MS genes in addition to 
ICL actually appeared to be retarded on plates supplemented with glyoxylate and succinate. This 
could be further evidence of the irreversibility of MS, as this growth retardation could be due to 
glyoxylate being drained away from ICL by the MS acting in the forward direction. 
 
3.4.3 Converting malate to glyoxylate and acetyl CoA 
To find a suitable alternative to E. coli MS, to metabolize malate into glyoxylate and acetyl-CoA, 
we sought enzymes that would couple this reaction with the hydrolysis of ATP to drive it in the 
desired direction. Such enzymes can be found in the serine cycle of type II methylotrophs, such as 
Methylobacterium extorquens. Here malyl-CoA is formed from malate and CoA by an ATP-
dependent malate thiokinase (MTK; ΔrG’°=-7.7 kJ/mol)7. Malyl-CoA is then cleaved into 
glyoxylate and acetyl-CoA by a malyl-CoA lyase (MCL; ΔrG’°=14.5 kJ/mol)7,11. MCLs are also 
involved in the 3-hydroxypropionate CO2 fixation pathway found in Chloroflexus auriantacus, 
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and (in the condensing direction) in the ethylmalonyl-CoA pathway of Rhodobacter sphaeroides 
and others. We tested in vivo activity of MTK/MCL combinations by employing the same selection 
used to evaluate AceB and GlcB reversibility. We expressed the enzymes together with Bs DctA, 
Ec AceA in the Glu- strain, and tested for growth on medium containing malate and succinate. We 
initially tested the well-characterized genes M. extorquens MtkAB and MclA12,13, and found that 
expression of these genes together did not rescue growth of the Glu- selection strain (data not 
shown).  
 
Therefore, we expressed homologous enzymes from various organisms in E. coli and tested them 
in vitro for “reverse MS” activity to find the most active variant. Since Mcl1 from R. sphaeroides 
(Rs Mcl1) has been actively expressed in E. coli14, we purified this protein and used it in excess in 
a coupled assay to test the activity of 15 putative MtkAB operons from various organisms 
expressed in E. coli (data not shown).  In this screen, SucCD-2 from Methylococcus capsulatus15 
(Mc SucCD-2), expressed from plasmid pSMg45, showed the greatest MTK activity (Figure 4A). 
Note that Mc SucCD-2 has been annotated as a succinyl-CoA synthetase, but here we showed that 
it has MTK activity. We then tested this enzyme in vivo (Figure 4B). When expressed together in 
the Glu- selection strain, Bs dctA, Mc sucCD-2,  Rs mcl1, and Ec AceA allowed for growth on 
glucose minimal medium with malate and succinate supplements, indicating that this MTK/MCL 
combination is active as a reverse MS (strain 6, Figure 4B).  We also observed growth (although 
more slowly) with addition of only succinate, which can be converted to malate by succinate 
dehydrogenase and fumarase. When either the ICL, the MTK, or the MCL was omitted  (Strains 
5, 7 or 8 respectively, Fig. 4B), no growth was observed on the selective plates, indicating that the 
overexpression of each enzyme is essential to the pathway in vivo. 
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These results show that malate can be converted to glyoxylate and acetyl-CoA at the expense of 
ATP. Therefore, by expressing Mc SucCD-2, Rs Mcl1, and Ec AceA, the glyoxylate shunt in E. 
coli is reversed, converting malate and succinate to acetyl-CoA and isocitrate using ATP to 
overcome the thermodynamic barrier.  
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Figure 4) Reversal of the glyoxylate shunt with heterologous genes. (A)MTK enzyme activity 
of M. capsulatus sucCD-2 was tested in vitro using lysate from E. coli cells expressing Mc SucCD-
2. Purified R. sphaeroides Mcl1 was used in excess in this coupled assay. (B)Versions of Glu- 
strain overexpressing combinations of heterologous MTK and MCL genes and native ICL were 
tested for their ability to grow on glucose minimal medium with the additives indicated beneath 
each plate. The strains tested expressed the malate transporter Bs dctA and (5) R. sphaeroides mcl1, 
M. capsulatus sucCD-2; (6) Ec aceA, Rs mcl1, Mc sucCD-2; (7) Ec aceA, Rs mcl1; (8) Ec aceA, 
Mc sucCD-2. Images were scanned after 4 days of incubation at 37°C. See Table 1 for strains’ 
detailed genotypes.  
  
3.4.4 Converting citrate to oxaloacetate and acetyl-CoA. 
With the input of two C4 compounds malate and succinate, the output of the reversed glyoxylate 
shunt is one acetyl-CoA and the C6 compound isocitrate. Therefore, we sought to extend the rGS 
to convert isocitrate back to the C4 compound OAA while releasing a second molecule of acetyl-
CoA. This involved reversing two enzymatic steps that are shared with the TCA cycle: readily 
reversible aconitase16, as well as citrate synthase (CS), which is not expected to be reversible 
(ΔrG’°=40.3 kJ/mol for reverse reaction)7. In E. coli, the reverse CS reaction could be performed 
by the concerted action of the native enzymes citrate lyase (CL) (citrate  oxaloacetate + acetate; 
ΔrG’°=0.6 kJ/mol)7 and acetate:CoA ligase (acetate + CoA + ATP  acetyl-CoA + AMP + PPi; 
ΔrG’°=2.0 kJ/mol)7. An alternative is the non-native ATP-citrate lyase (ACL) that performs the 
ATP-dependent conversion of citrate directly to oxaloacetate and acetyl-CoA (ΔrG’°=2.7 kJ/mol)7. 
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This enzyme is found in most eukaryotes, and archaea that fix carbon via the reductive TCA 
cycle17-19. 
 
To test these various options for “reverse citrate synthase” activity in vivo, we created an aspartate 
auxotrophic E. coli mutant strain, (ΔgltA Δppc Δmdh Δmqo ΔcitE), hereafter referred to as Asp- 
(Fig. 5).  The Asp- strain is deleted of all enzymes that produce the aspartate precursor OAA (ppc, 
mdh, mqo) and is also deleted of the genes that could have reverse citrate synthase activity (gltA, 
citE). For the ‘reverse citrate synthase’ assay, we also expressed the recombinant citrate transporter 
CitA from Salmonella enterica20 (Se CitA), to enable citrate uptake from the medium. This strain 
should only be able to grow on minimal medium supplemented with citrate if it is able to convert 
citrate provided in the medium to OAA, an aspartate precursor (Strain 9, Fig. 6A). As expected, 
overexpression of E. coli citrate synthase gltA did not restore growth on citrate containing plates 
(Strain 10, Figure 6A). We also determined that native expression levels of citrate lyase citDEF 
were unable to restore growth (Strain 11 Fig. 6A: Asp- strain without citE knockout). This could 
be due to repression of the citrate lyase operon under aerobic conditions. Instead of overexpressing 
the citrate lyase operon together with the acetate:CoA ligase, we  tested the activity of the more 
direct ATP-citrate lyase from Chlorobium tepidum (Ct AclAB)21. We expressed Ct AclAB in the 
Asp- strain and found that this heterologous enzyme allowed for growth on citrate-supplemented 
medium, providing evidence that this enzyme was active in vivo and formed the essential 
intermediate OAA from citrate (Strain 12, Fig. 6A). The activity of Ct ACL was confirmed in vitro 
in an enzyme assay using His-tagged protein purified from E. coli (Fig. 6B). 
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As was the case with malate synthase reversal, use of an ATP-coupled enzyme enabled the initially 
unfavorable reverse reaction of citrate synthase. 
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Figure 5) Genetic context used for testing ability of rGC genes to produce oxaloacetate. This 
diagram represents the aspartate auxotroph selection strain (Asp-) used to test the reversibility of 
the extended glyoxylate shunt pathway in vivo. Black lines show the native E. coli metabolism. 
‘✕’ indicates that the reaction has been interrupted by gene knockouts. Green lines show the 
successful strategy to reverse glyoxylate shunt and complement aspartate auxotrophy. Note that 
the gltA and citDEF reactions were also individually tested for OAA formation from citrate (see 
Figure 6). Open block arrows indicate carbon sources supplied in the growth medium. 
  
3.4.5. Optimization of the isocitrate branchpoint. 
After testing the thermodynamically challenging steps of our pathway individually, we then tested 
activity of multiple steps in concert. First we tested if combined overexpression of Ct AclAB and 
Ec AceA could allow the Asp- strain to grow on glucose minimal medium supplemented with 
glyoxylate and succinate. Here, the strain is expected to grow only if glyoxylate and succinate can 
be condensed to isocitrate, and if that, in turn, can be converted to citrate by the aconitases (via 
aconitate). Citrate would then act as a substrate for ACL to produce OAA and rescue the aspartate 
auxotrophy. As a precaution, we deleted malate synthase aceB to prevent loss of glyoxylate to 
malate. As shown in Figure 6C (strain 15), extremely slow growth was observed under these 
conditions. We hypothesized this was due to isocitrate being drained away from the aconitases 
(ACN) by isocitrate dehydrogenase (ICD), which competes for the same substrate (see Figure 5). 
Thus, we sought to tune the isocitrate branchpoint to favor our pathway, by i) overexpressing each 
of the two native E. coli aconitases acnA and acnB, ii) deleting the icd gene, or iii) combining these 
69 
 
two modifications. As indicated by the growth rate of the various strains tested on a medium 
supplemented with glyoxylate and succinate, the metabolic flux was best channeled into our 
pathway by combining icd deletion and acnA overexpression (strain 13, Figure 6C). 
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Figure 6) Activity of pathways from citrate to OAA.  (A) Versions of Asp- expressing the citrate 
transporter citA from S. enterica were grown on glucose minimal medium with citrate to test three 
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OAA production pathways: (9) none overexpressed, CL knockout; (10) Ec gltA overexpression, 
CL knockout; (11) none overexpressed, native expression of CL; (12) overexpression of C. 
tepidum aclAB, CL knockout. Plates were scanned after 2 days of incubation at 37°C. (B) Enzyme 
activity of purified ACL was tested in vitro. Commercial malate dehydrogenase was used in excess 
in this coupled assay. (C) Optimization of isocitrate branchpoint. The effect of icd deletion and 
Ec acnA or Ec acnB overexpression were tested in combination (Strains 13-18, see graph inset) in 
the Asp- strain expressing Ec aceA. Growth was tested in liquid minimal glucose medium 
supplemented with glyoxylate and succinate.  
 
3.4.6. Assembly of the full pathway from malate and succinate to acetyl-CoA and OAA. 
Having identified active enzymes for each step and optimized the critical branchpoint, we 
incorporated all these features into the Asp- strain, and tested whether the full pathway could 
provide OAA to support growth from malate and succinate. We overexpressed Bs dctA, Mc 
sucCD-2 and Rs mcl1 in the Asp- strain withicd and aceB knockouts, together with Ec aceA, Ec 
acnA and Ct aclAB. This strain was able to grow on glucose minimal medium supplemented with 
malate and succinate (Strain 19, Figure 7A-B). Control strains missing key genes of the pathway 
(aclAB, or aceA and acnA, or mcl1; Strains 179, 180 and 181 respectively) were not able to grow 
under these conditions, and growth of the strain containing the full pathway is dependent on the 
presence of malate and succinate. The same result was shown in an acetyl-CoA auxotroph as well.  
We employed a strain with aceF and icd knocked out. AceF encodes for a subunit of pyruvate 
dehydrogenase in E. coli, without which E. coli is unable to grow in glucose minimal medium 
without the supplementation of acetyl-CoA. Icd is knocked out to prevent competition with the 
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rGS with result shown in Figure 8. Result showed that with glucose and malate feed to the medium, 
The strain is only able to grow with the full rGS pathway along with aceB, showing that the 
complete rGS pathway is capable of supporting growth of an acetyl-CoA auxotroph by supplying 
acetyl-CoA from the pathway. From the two experiments, the results demonstrate a complete in 
vivo reversal of the glyoxylate pathway from malate and succinate to OAA and two molecules of 
acetyl-CoA.  
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Figure 7) Pathway from malate to OAA. (A) Growth of the optimized Asp- strain on minimal 
medium supplemented with glucose and 10 mM of the supplement indicated below each plate. In 
addition to expressing the malate transporter Bs dctA, strain (19) expressed Mc sucCD-2, Rs mcl1, 
74 
 
Ec aceA, and Ct aclAB. Negative control strains do not overexpress the following genes: (20) no 
aclAB; (21) no mcl1; (22) no acnA and aceA. Plates were scanned after 7 days of incubation at 
37°C.  See Table 1 for strains’ detailed genotypes. (B) Growth rates of strain (19) (triangles) and 
(21) (squares) were compared in liquid glucose minimal medium supplemented with aspartate 
(short-dashed lines); malate and succinate (solid lines); or without supplement (long-dashed lines).  
 
 
 
Figure 8) Supporting the growth of the acetyl-CoA auxotroph with the rGS pathway. The 
strain (BW25113aceFicd) harboring the said plasmid was grown in Vogel-Bonner Medium with 
1% glucose, 10mM malate and 10mM glutamate. The orange line was the only strain that 
overexpressed the complete rGS pathway along with aceB, with the others as the negative control. 
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The error bars shows the standard deviation of the growth of three colonies picked from the same 
LB plate after the transformation. 
 
3.4.7. Evolution of the Asp- strain Overexpressing ICL and ACL 
In observation of the slow growth in the Asp- strain overexpressing the ICL and ACL in glucose 
minimal medium, we did a directed evolution based on SM135 grown in minimal medium 
containing decreasing amount of glucose.  The result and the carbon source profile of the culture 
is shown in Figure 9A-B. Evolution result shows that after the initial passes, the strain already 
showed faster growth rates, showing that subsequent passes of the strain improves growth rate. 
With a decreasing amount of glutamate, the growth was retarded, indicating that glutamate is more 
essential than glucose in the growth process. As the evolution progressed, the cells grow at faster 
rate with less amount of carbon source. In the end with only 2.5mM glutamate, 5mM succinate 
and glyoxylate respectively, the saturated O.D. drops to around 0.4-0.5, showing that the evolution 
stopped somehow. After evolution of the strain, we noticed that the strain was able to grow on 
succinate only medium (data not shown). In search for the mutation that caused the strain to grow 
in succinate only medium, we sequenced the evolved strain in comparison with the unevolved 
SM135 but none of the potential mutations matched with the production of OAA. We later found 
that aspA, which encodes for aspartate amino-lyase (aspartase)22, is responsible for the amination 
of fumarate to make aspartate and that was the reason why the strain was able to grow in minimal 
medium with succinate and glutamate as the carbon sources. Although the directed evolution 
efforts did not lead to improvement of the rGS pathway, we demonstrated the growth enhancement 
of the Asp- strain and the potential of subsequent passing in effort to improve the pathway. 
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Figure 9) Evolution profile of SM135c in M9 medium containing 40M calcium pantothenate. 
A) shows the growth curve of each dilutions and B) shows the change in composition of the 
evolution medium. 
 
 
3.5. Discussion  
Here we employed thermodynamic principles to engineer a pathway in a naturally unfavorable 
direction, utilizing ATP hydrolysis to drive key steps. We used genetic selections to demonstrate 
activity of each step of the pathway individually and in combination. Metabolic engineering of 
native genes was required to direct flux in the desired direction. We also demonstrated the potential 
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benefits of directed evolution in for slow growing strains. This study adds a novel pathway to the 
toolkit of metabolic engineers that allows for conversion of C4 carboxylic acids to acetyl-CoA 
without carbon loss as CO2.  
There are a number of uses for this pathway based on an rGS. Extension of the pathway by addition 
of malate dehydrogenase (MDH) would connect OAA to malate and allow for malate to cycle 
while converting succinate to acetyl-CoA. This would effectively reverse the glyoxylate cycle. 
Our genetic selection did not allow us to test integration of MDH with the rGS pathway, but this 
gene is native to E. coli and fully reversible. Separately, to convert malate to succinate and 
integrate the pathway described here with central metabolism, two additional enzymes (not 
formally involved in the glyoxylate cycle) would be required: a fumarase and a fumarate reductase. 
E. coli encodes three fumarases, of which at least one is expressed during either aerobic or 
anaerobic conditions23. Fumarate reductase (Frd) is generally only expressed anaerobically24, and 
may need to be deregulated for full pathway integration.  Deregulated Frd mutants have been 
previously found in selections for aerobic growth in succinate dehydrogenase null strains25. 
 If integrated with central metabolism, for example via the native E. coli phosphoenolpyruvate 
carboxylase, such a pathway could theoretically allow for the conversion of one mole of glucose 
to 3 moles of acetyl-CoA, thus achieving a 50% yield increase over glycolysis. This yield increase 
can be channeled into industrially relevant compounds such as isoprenoids, fatty acids or long 
chain alcohols (see Figure 1). The rGS pathway also allows conversion of a number of amino acids 
to acetyl-CoA at higher carbon yields than other known pathways. Protein-to-biofuel conversion 
has been of interest and would benefit from this pathway26. Finally a novel CO2 fixation cycle 
could be built upon the pathway described here. Addition of one enzyme to convert acetyl-CoA 
into pyruvate (e.g., pyruvate ferredoxin oxidoreductase) would close the linear CO2 fixation 
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pathway into a cycle and could theoretically allow growth with CO2 as the sole carbon source, if 
a source of reducing power were provided. A number of organisms grow autotrophically without 
any of the known carbon fixation pathways (for review, see Berg 201127). Based on the repertoire 
of known metabolites and enzymes, Bar-Even et al.28 recently computed alternatives to the known 
CO2 fixation pathways, including a pathway based on a reverse glyoxylate shunt as a theoretically 
possible cycle. Here we show that with the introduction of 3 foreign enzymes, appropriate 
metabolic tuning, and introduction of ATP-driving forces the reverse glyoxylate shunt pathway 
operates in vivo in E. coli.  
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3.6. Tables 
 
STRAINS 
# in 
text 
Strain 
name 
Relevant genotype Plasmid(s) Reference 
 JCL16 rrnBT14 ΔlacZWJ16 hsdR514 
ΔaraBADAH33 ΔrhaBADLD78 /F’[traD36 
proAB+ lacIqZ ΔM15] 
- Atsumi et 
al., 2008 
 JW3928 BW25113 (rrnB3 ΔlacZ4787 hsdR514 
Δ(araBAD)567 Δ(rhaBAD)568 rph-1) 
Δppc 
- Baba et al., 
2006 
 SM43 JW3928 pSM13 This work 
 SM44 JW3928 pSM22 This work 
1 SM160 JCL16 ΔgltA ΔprpC pSM22 pSMc00 pYK This work 
2 SM161 JCL16 ΔgltA ΔprpC pSM22 pSMc00 pLG5 This work 
3 SM163 JCL16 ΔgltA ΔprpC pSM22 pSM12 pLG5 This work 
4 SM162 JCL16 ΔgltA ΔprpC pSM22 pSM11 pLG5 This work 
5 SM164 JCL16 ΔgltA ΔprpC pSM22 pSM62 pYK This work 
6 SM165 JCL16 ΔgltA ΔprpC pSM22 pSM62 pLG5 This work 
7 SM167 JCL16 ΔgltA ΔprpC pSM22 pSM62ΔMTK pLG5 This work 
8 SM166 JCL16 ΔgltA ΔprpC pSM22 pSM62ΔMCL pLG5 This work 
9 SM169 JCL16 ΔgltA Δmdh Δppc ΔcitE Δmqo pSM01 pYK This work 
10 SM170 JCL16 ΔgltA Δmdh Δppc ΔcitE Δmqo pSM01 pGltA This work 
11 SM172 JCL16 ΔgltA Δmdh Δppc Δmqo pSM01 pYK This work 
12 SM171 JCL16 ΔgltA Δmdh Δppc ΔcitE Δmqo pSM01 pSMb02 This work 
13 SM93a  JCL16 ΔgltA Δmdh Δppc ΔcitE Δmqo 
ΔaceB 
pSMf02 pLG5 pSM69 This work 
14 SM93b JCL16 ΔgltA Δmdh Δppc ΔcitE Δmqo 
ΔaceB 
pSMf02 pLG5 pSM70 This work 
15 SM93c JCL16 ΔgltA Δmdh Δppc ΔcitE Δmqo 
ΔaceB 
pSMf02 pLG5 pSM71 This work 
16 SM135a JCL16 ΔgltA Δmdh Δppc ΔcitE Δmqo 
ΔaceB Δicd 
pSMf02 pLG5 pSM69 This work 
17 SM135b JCL16 ΔgltA Δmdh Δppc ΔcitE Δmqo 
ΔaceB Δicd 
pSMf02 pLG5 pSM70 This work 
18 SM135c JCL16 ΔgltA Δmdh Δppc ΔcitE Δmqo 
ΔaceB Δicd 
pSMf02 pLG5 pSM71 This work 
19 SM178 JCL16 ΔgltA Δmdh Δppc ΔcitE Δmqo 
ΔaceB Δicd 
pSM22 pSM73 pSMf02 
pSM62+ 
This work 
20 SM179 JCL16 ΔgltA Δmdh Δppc ΔcitE Δmqo 
ΔaceB Δicd 
pSM22 pSM73 pSMf00 
pSM62+ 
This work 
21 SM181 JCL16 ΔgltA Δmdh Δppc ΔcitE Δmqo 
ΔaceB Δicd 
pSM22 pSM73 pSMf02 
pSM62+ΔMCL 
This work 
22 SM180 JCL16 ΔgltA Δmdh Δppc ΔcitE Δmqo 
ΔaceB Δicd 
pSM22 pYK pSMb02 
pSM62+ 
This work 
PLASMIDS 
Plasmid name Description Reference 
pSS25 CDF-ori, SpR, LacI, PLlacO1:his-tag aceA(Ec) This work 
pXL18-4 ColE1-ori, SpR, lacI, PLlacO1:AclB(Ct):RBS:AclA(Ct) his-tag This work 
pSMg45 CDF-ori, SpR, LacI, T7:his-tag SucCD-2 (Mc) This work 
pSMg59 CDF-ori, SpR, LacI, T7:his-tag Mcl1 (Rs) This work 
pGltA ColA ori, KmR, LacI, PLlacO1:GltA(Ec) This work 
pLG5 ColA ori, KmR, LacI, PLlacO1:AceA(Ec) This work 
pSM22 pSC101* ori, SpR, PLlacO1:DctA(Bs) This work 
pSM69 pSC101* ori, SpR, PLlacO1:AcnA(Ec) This work 
pSMf02 p15A ori, AmpR, LacI, PLlacO1:AclB(Ct):RBS:AclA(Ct) This work 
pSMb02 ColA ori, KmR, LacI, PLlacO1:AclB(Ct):RBS:AclA(Ct) This work 
pSM70 pSC101* ori, SpR, PLlacO1:AcnB(Ec) This work 
pSM71 pSC101* ori, SpR, empty This work 
pYK ColA ori, KmR, LacI, empty This work 
pSMc00 p15A ori, CmR, empty This work 
pSM11 p15A ori, CmR, PLlacO1:GlcB(Ec) This work 
pSM12 p15A ori, CmR, PLlacO1:AceB(Ec) This work 
pSM73 ColA ori, KmR, LacI, PLlacO1:AceA(Ec), PLlacO1:AcnA(Ec) This work 
pSM13 pSC101* ori, SpR, PLlacO1:DctA(Ec) This work 
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pSM62 p15A ori, CmR, PLlacO1:SucCD-2(Mc):RBS:Mcl1(Rs) This work 
pSM62ΔMCL p15A ori, CmR, PLlacO1:SucCD-2(Mc) This work 
pSM62ΔMTK p15A ori, CmR, PLlacO1:Mcl1(Rs) This work 
pSM62+ ColE1 ori, CmR, PLlacO1:SucCD-2(Mc):RBS:Mcl1(Rs) This work 
pSM62+ΔMCL ColE1 ori, CmR, PLlacO1:SucCD-2(Mc) This work 
pSM01 pSC101* ori, AmpR, PLlacO1:CitA(Se) This work 
pSMc90 p15A ori, CmR, PLlacO1:SucCD-2(Mc):RBS:Mcl1(Rs), 
PLlacO1:AclB(Ct):RBS:AclA(Ct) 
This work 
pSMc91 p15A ori, CmR, PLlacO1: Mcl1(Rs) PLlacO1:AclB(Ct):RBS:AclA(Ct) This work 
pSMc92 p15A ori, CmR, PLlacO1:SucCD-2(Mc):RBS:Mcl1(Rs)  This work 
pLG150 ColA ori, KmR, LacI, PLlacO1:AceA(Ec), PLlacO1:AcnA(Ec), 
PLlacO1:AceB(Ec) 
This work 
pLG150 ColA ori, KmR, LacI, PLlacO1:AcnA(Ec), PLlacO1:AceB(Ec) This work 
 
 
Table 1) Strains and plasmids used in the study. SpR: Spectinomycin resistant; KmR: 
Kanamycin resistant; AmpR: Ampicillin resistant; CmR: Chloramphenicol resistant; RBS: 5’-
AGGAGA-3’; Bs: Bacillus subtilis; Ec: Escherischia coli; Ct: Chlorobium tepidum; Mc: 
Methylococcus capsulatus; Rs: Rhodobacter sphaeroides; Se: Salmonella enterica. 
Plasmids used in final, full-pathway strain, complete plasmid sequence in Supplementary 
Information.  
 
 
 
 
Strain 
name 
Relevant 
mutation 
Gene 
overexpressed 
Growth on 
M9 glucose 
Growth on 
M9 glucose + 
malate 
Growth on 
M9 glucose + 
succinate 
JW3928 Δppc none - + +++ 
SM43 Δppc Ec DctA - + +++ 
SM44 Δppc Bs DctA - +++ +++ 
 
Table 2: Bacillus subtilis DctA transporter allows malate uptake in E. coli Δppc mutant. Growth 
of E. coli strains JW3928, SM43 and SM44 were grown on M9 plates 2% Glucose 100 M IPTG 
with no supplements, or supplemented with 20 mM malate or succinate. - : no growth; +: poor 
growth; +++: healthy growth. Plate photographs are shown in supplementary Figure 1. 
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Chapter 4. The Reverse Glyoxylate Shunt-2 
 
Disclaimer: This chapter is written partly in preparation for submission for publication after 
this thesis is filed. 
 
 
4.1. Abstract 
Acetyl-CoA is one of the most important compounds in biochemical productions. Whether 
produced from pentose or hexose, it will involve the conversion of a C3 into a C2, which requires 
pyruvate dehydrogenase, pyruvate decarboxylase, pyruvate oxidoreductase or pyruvate formate-
lyase. In the course of the conversion, a C1 molecule will be lost per molecule of pyruvate reacted. 
To alleviate the problem, we constructed the reverse glyoxylate shunt-2 (rGS-2). This work is 
developed based on our previous work in the first reverse glyoxylate shunt1, which possessed the 
potential of converting one molecule of glucose into four molecules of acetyl-CoA with the 
fixation of two molecules of carbon dioxide. However, there are potential kinetic problems in the 
previous reverse glyoxylate shunt. In this part of the thesis, a partially reversed glyoxylate shunt 
is coupled with the native glyoxylate degradation pathway in E. coli into a new pathway to 
demonstrate the possibility of alternative pathway to convert pyruvate into acetyl-CoA with the 
complete conservation of carbon. 
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4.2. Introduction 
In effort to reduce carbon dioxide emission, sustainable methods to produce fuel and commodity 
chemicals has been developed through metabolic engineering and synthetic biology. For instance, 
the clostridial ABE fermentation, as mentioned in the introduction, has been employed to produce 
acetone from glucose since the 1920s2. Sugar employed in the biofuel and biochemical production 
will first require being broken down into simpler molecules of two-carbon chains or three-carbon 
chains3–6. The glycolytic7 and pentose phosphate pathways8 involves breaking down the sugar 
chains of six to five carbons into the three-carbon intermediate pyruvate. As for using CO2 as the 
feedstock, aside from the reductive acetyl-CoA pathway9 and the reductive tricarboxylic acid 
cycle10, the Calvin-Benson-Bassham cycle11 and the 3-hydroxypropanoate pathway12 fix carbon 
dioxide and produces C3 compounds as the main product. The three-carbon carriers will need to 
be broken down into two-carbon carriers, which are essential in biochemical and production as 
well. The ABE fermentation and isopropanol production pathway requires acetyl-CoA as an 
intermediate, for example. Acetyl-CoA is the building block in fatty acid synthesis which will, in 
turn, be involved in the production of long chain alkanes or alkenes, fatty alcohols and polyketides. 
However, the conversion of three-carbon carriers into two-carbon carriers, whether through 
pyruvate dehydrogenase, pyruvate decarboxylase or pyruvate formate-lyase, is not a carbon 
efficient process, involving the loss of one carbon as CO2 or formate. In effort to alleviate this 
problem, a non-oxidative glycolytic pathway (NOG) has been developed by Bogorad et al.13. The 
pathway was shown to be capable of the nearly complete conversion of one moles of fructose-6-
phosphate into three molecules of acetyl phosphate in vitro and the almost complete conversion of 
two mole of xylose into five mole of acetyl phosphate in vivo. The pathway focuses on the 
reconstitution of the carbon in fructose-6-phosphate through carbon rearrangement and rerouting 
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glycolysis. In this part of the chapter, we would like to present another version of the reverse 
glyoxylate shunt that directly passes the decarboxylation step from pyruvate to acetyl-CoA and 
achieve the same carbon yield as the NOG pathway or with supply of NADH, will be able to fix 
more CO2 to make one more molecule of acetyl-CoA. 
In the previous chapter, we presented the reverse glyoxylate shunt (rGS-1) which was capable of 
converting one molecule of malate and one molecule of succinate into two molecules of acetyl-
CoA and one molecule of oxaloacetate1. In turn, a C4 is converted into two C2. We have not shown 
that acetate was actually produced in the course of the conversion. Moreoever, there is a kinetic 
trap in the reverse glyoxylate shunt. There are two key steps in the pathway, the splitting of malate 
into glyoxylate and acetyl-CoA with the help of CoA and the combination of glyoxylate and 
succinate to form isocitrate. The reversal of isocitrate lyase requires equimolar amount of 
glyoxylate and succinate in the cycle, requiring a delicate balance in the metabolic flux towards 
glyoxylate and succinate respectively and hence, the irreversibility of malate thiokinase poses a 
kinetic trap in the cycle. Bifurcation robustness analysis showed that in the previous glyoxylate 
shunt, if malate thiokinase is an irreversible step, whenever the malate thiokinase activities are 
perturbed, there is a high chance that the system is going fail14. In search for a more stable pathway, 
we can either add a reverse step, malate synthase to the pathway or bypass the use of reverse 
isocitrate lyase.  
In this chapter, we designed a second version of a partially reversed glyoxylate shunt. Instead of 
directing the glyoxylate to the reversal of isocitrate lyase, the glyoxylate flux is directed towards 
the native E. coli glyoxylate degradation pathway. Krakow and Barkulis first described the first 
step of the glyoxylate degradation pathway15, glyoxylate carboligase, where they observed the 
oxidation of glyoxylate by extract from E. coli grown in mineral medium with glycolate as the sole 
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carbon source. With the glyoxylate degradation pathway, two molecules of glyoxylate are ligated 
with the loss of a molecule of CO2 to form a C3 compound, tartronate semialdehyde, which is 
further converted into 2-phosphoglycerate and back to central metabolism in glycolysis and the 
tricarboxylic acid cycle. The detailed design of the pathway is shown in Fig. 4.1. In addition to the 
capability of complete conversion of glucose into acetate, the pathway possesses the potential of 
fixation two more molecules of CO2 to make four molecules of acetate from one molecules of 
glucose with the addition of reducing power and ATP. 
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Figure 4.1. The design of the rGS-2 pathway. (A) shows the pathway capable of complete 
conversion of glucose into acetate and (B) shows the pathway with additional CO2 fixation. 
Enzyme abbreviations: pyk, pyruvate kinase; ppc, PEP carboxylase; mdh, malate dehydrogenase; 
mtk, malate thiokinase; mcl, malyl-CoA lyase; gcl, glyoxylate carboxyligase; glxR, tartronate-
semialdehyde reductase; glxK, garK, glycerate kinase; eno, enolase; pdh, pyruvate dehydrogenase; 
ack, acetyl-CoA kinase; pta, phosphotransacetylase. 
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4.3. Methods 
 
4.3.1 Strain construction  
All strains used in this study are listed in Table 4.1. JCL16(rrnBT14 ΔlacZWJ16 hsdR514 
ΔaraBADAH33 ΔrhaBADLD78/F’ [traD36 proAB+ lacIqZΔM15]) was used as the wild type for the 
“acetyl-CoA auxotroph”. E. coli K-12 MC4100 (F- [araD139]B/r Δ(argF-lac)169* &lambda- e14- 
flhD5301 Δ(fruK-yeiR)725 (fruA25)‡ relA1 rpsL150(strR) rbsR22 Δ(fimB-fimE)632(::IS1) deoC1) 
was used to build the “pyruvate auxotroph”. Gene deletions were done with P1 transduction 
techniques with single knockout strains from Keio Collection16. The gene knockouts were verified 
by PCR with primers flanking the deleted locus. The primer lists are shown in Table 1A and the 
E. coli strains used in this study is listed in Table 1B.  
 
4.3.2. Plasmid Construction 
For plasmids with RBS optimization, the RBS calculator by Denovo DNA was employed to 
maximize the expression rate17,18. All plasmids used in this study were constructed with isothermal 
Gibson DNA assembly or T4 DNA polymerase (NEB Biolabs). Backbones and inserts of the 
plasmids with overlapping region of 20-25 bp on each end were amplified with either KOD or 
KOD xtreme hot start polymerase (EMD Millipore). The PCR products were then gel-purified and 
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mixed in equimolar amounts with a final volume of 2.5L. 7.5 L of the premixed solution [6.65% 
PEG-8000, 133 mM Tris–HCl, pH 7.5, 13.3 mM MgCl2, 13.3 mM DTT, 0.27 mM each of the 
four dNTPs, 1.33 mM NAD+, 0.08 U T5 exonuclease (Epicentre), 0.5 U Phusion Polymerase 
(NEB), 80 U Taq DNA ligase (NEB) in water] was then added for the DNA mixed, which was 
vortexed and centrifuged for incubation at 50oC for 1hour. The whole mixture is then mixed with 
Z-competent (Zymo Research) XL-1 Blue E. coli cells for transformation. The transformants were 
then plated onto LB Agar plate containing the respective antibiotics. Three colonies were then 
picked from each plate for plasmid purification and verification by sequencing. The plasmids used 
in this study are listed in Table 2. 
 
4.3.4. Growth Conditions 
For growth selection in minimal media, E. coli cells were first picked from single colony on LB 
agar plate and incubated in LB medium at 37oC and agitated at 250 rpm for an overnight culture. 
The overnight culture was then transfer to fresh LB medium and grown until mid-log phase. 1 mM 
Isopropyl--D-thio-galactoside (IPTG, Zymo Research) was then added into each of the culture to 
induced the production of the protein of interest in room temperature for an overnight. Cells were 
harvested by centrifugation at 3600 x g for five minutes and washed three times with equal volumes 
of the minimal medium. The cells were then resuspended in the same volume of the minimal 
medium of the test. A 3.3% inoculation is then added into the medium for the test.  The media for 
the growth tests contained M9 minimal salts, 1mM MgSO4, 0.1mM CaCl2, 0.1mg/mL thiamine 
hydrochloride, 0.1mM IPTG and the appropriate antibiotics at the following concentrations: 
Kanamycin 40μg/mL, Chloramphenicol 25μg/mL, Ampicillin 100μg/mL, Spectinomycin 
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100μg/mL, Gentamycin 25μg/mL (all from Sigma Aldrich). The media were further supplemented 
with the carbon sources as noted in the data with a combination of 1% glucose, 10mM sodium 
acetate, 50 mM sodium glyoxyate or 50 mM sodium fumarate (all from Sigma Aldrich). As for 
anaerobic rescue with JCL166, the medium contains terrific broth (TB) (Fisher Scientific), 
supplemented by either 1% glucose or 1% xylose, 0.1mM IPTG, the appropriate antibiotics at the 
same concentration mentioned above and varying concentration of glyoxylate. 
For anaerobic cultures, the culture is transferred to a BD vacutainer glass tube (Beckton Dickson) 
where it rubber cap was punctured with a needle topped by a 0.22m filter (EMD Millipore). The 
experimental apparatus was then put under vacuum and purged with pure nitrogen twice and 
finally with mixed nitrogen and hydrogen with 5% of hydrogen. The needles were later taken out 
inside an anaerobic chamber and the whole culture is moved to a 37oC incubator shaken at 250rpm. 
 For growth test done in a plate reader, 200L of the minimal medium was transferred to each of 
the wells in a sterile 96-well microplate and 6L of the washed culture was added to each of the 
wells. The lid and the microplate are taped together with a labelling tape. A blank containing no 
E. coli cells was kept as the blank for the whole course of optical density measurement. The 
microplate reader was set at 37oC with orbital continuous shaking of frequency 237cpm for 72 
hours. The O.D.600 readings were taken automatically with a 15 mins interval at normal read speed. 
 
4.3.5 Enzyme assays 
Coupled Assay of Malate thiokinase (mtk) and Malyl-CoA(mcl) lyase 
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The native mtk(s) from different sources were cloned under the control of a pLlacO1 promoter 
with the RBS optimized by the RBS calculator17,18. The mtk(s) from Mesorihizobium loti (Ml), 
Methylobacterium extorquens (Me), Methylobacterium radiotolerans (Mr), Nitrosomonas 
europaea (Ne) were cloned into a plasmid backbone of KmR with ColA origin and overexpressed 
in SS109. The cells were grown to mid-log phase in LB medium and induced by 1mM IPTG 
overnight at room temperature. The cells were then harvested by centrifugation, resuspended in 
0.25M Tris-HCl pH 7.5 and lysed by sonication. Cell debris were removed by centrifugation and 
total soluble protein contents were measured by Bradford assay. 
Mtk performs the ATP-dependent thiokinase reaction and forms a malyl-CoA and mcl, in turn, 
lyses malyl-CoA into acetyl-CoA and glyoxylate which will then react with phenylhydrazine to 
form glyoxylate-phenylhydrazone. The rate of glyoxylate-phenylhydrazone formation is measured 
at 324nm in a spectrophotometer.  Reaction was set up for a final volume of 1mL with the reaction 
medium containing 50mM Tris-Cl pH 7.5, 5mM MgCl2, 2mM phenylhydrazine, 10mM malate, 
2mM ATP, 1mM CoA. The reaction is started by adding 20L of the crude extract and the 
absorbance at 324nm is recorded for 15 minutes. The specific activities are normalized against the 
mass of protein the in the crude extract. 
Coupled Assay of PEP Carboxylase and Malate Dehydrogenase 
E. coli PEP Carboxylase (ppc) and malate dehydrogenase (mdh) was expressed in JCL166 
harboring pFD245. The strain was cultured in LB medium and induced at mid-log phase with 1mM 
of IPTG in room temperature for an overnight. The cells were then harvested by centrifugation at 
3500xg for 20mins. The pellet was resuspended in 1mL 100mM Tris-HCl pH7.5 and lysed with a 
sonicator. The lysate was then centrifuged at 16200xg for 10 mins at 4oC to remove the cell debris. 
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The supernatant was then taken for measurement. Reaction was set up for a final volume of 1mL 
with the reaction medium containing 100 mM Tris-Cl pH 7.5, 5 mM MgCl2, 0.4 mM acetyl-CoA, 
4 mM phosphoenoylpyruvate, 15 mM NaHCO3, 0.2mM NADH. The reaction is started by adding 
20L of the crude extract and the absorbance at 340nm is recorded for 15 minutes. 
Coupled Assay of Glyoxylate Carboligase and Tartronate-semialdehyde Reductase 
E. coli glyoxylate carboligase (gcl) and Tartronate-semialdehyde reductase (glxR) were 
overexpressed in JCL166 harboring the plasmid pSS81. The strain was cultured in LB medium 
and induced at mid-log phase with 1mM of IPTG in room temperature for an overnight. The cells 
were then harvested by centrifugation at 3500xg for 20mins. The pellet was resuspended in 1mL 
100mM sodium phosphate (pH 8.0) and lysed with a sonicator. The lysate was then centrifuged at 
16200xg for 10 mins at 4oC to remove the cell debris. The supernatant was then taken for 
measurement. Reaction was set up for a final volume of 1mL with the reaction medium containing 
100 mM sodium phosphate (pH. 8.0), 5mM MgCl2, 0.28mM NADH, 0.5mM thiamin 
pyrophosphate and 10mM sodium glyoxylate. The reaction was started by adding 10Lof the 
crude extract into the reaction mixture and the change in absorbance at 340nm was monitored with 
a spectrophotometer 
Enzyme Assay of Formate Dehydrogenase 
C. boidinii formate dehydrogenase was overexpressed in JCL166 harboring the plasmid pFD254. 
The cell culture and lysis steps were described above. The reaction was set up for a final volume 
of 1mL with the reaction medium containing 100 mM potassium phosphate (pH 7.5), 30mM 
sodium formate, 0.5mM NAD+. The reaction is started by adding 20L of the crude extract and 
the increase in absorbance at 340nm is recorded for 15 minutes. 
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4.3.6. Production of Acetate 
For production in rich and minimal medium, E. coli cells were first picked from single colony on 
LB agar plate and incubated in LB medium at 37oC and shaken at 250 rpm for an overnight culture. 
The overnight culture was then transfer to fresh LB medium and grown until mid-log phase in a 
baffled shake flask. 1 mM Isopropyl--D-thio-galactoside (IPTG, Zymo Research) was then added 
into each of the culture to induced the production of the protein of interest in room temperature for 
an overnight. Cells were harvested by centrifugation at 3500 x g for thirty minutes and resuspended 
in 10 times less volume of the original volume of Terrific broth (TB, Fisher scientific) with 1% 
glucose and 0.1mM IPTG supplemented with the appropriate amount of antibiotics listed in growth 
conditions. The culture was resuspended to an O.D. around 15 and shaken at 37oC in an 18mm 
diameter glass tube. Time points were taken accordingly by centrifuging 500L of the culture at 
6000rpm for 5 minutes. The supernatant was filter with Amicon 10kDa protein filters (EMD-
Amicon), diluted to 10 times of the original concentration and analyzed in the HPLC with 210nm 
for the quantification of acetic acid and with the Refractive index detector. For microaerobic 
productions, the resuspend cultures were shaken in BD vacutainer glass tube capped in room 
conditions. As for 13C-labelled glucose experiment, medium was prepared as stated above except 
that glucose is replaced by D-Glucose-13C6 (CAS 110187-42-3) (Santa Cruz Biotechnology). The 
glucose content in the samples were analyzed by the derivatization of glucose with phenyl-
hydrazine at room temperature for 20 minutes followed by the quantification in the LC-MS at 
wavelength 300nm with molecular weight 286 g/mol. The total amount of acetate is quantified by 
the HPLC at 210nm and the ratio of labelled acetate (MW 61g/mol, 62g/mol) to unlabeled acetate 
(MW 60g/mol) is determined by analysis of the samples in the GC-MS.  
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4.4. Results and Discussion 
 
4.4.1. Bioprospecting Mtk mcl 
From our previous work in rGS-1, we observed that when mtk mcl was overexpressed in the OAA 
auxotroph to produce glyoxylate for the growth rescue, the time required to perform the growth 
rescue increased from four days to seven days1. We then noticed that in the rGS-2, mtk mcl 
activities has to be improved. First, we cloned another mcl from M. extorquens and found that the 
activities was higher than that from R. sphaeroides. With that finding, we cloned four more mtk(s) 
from different organisms and optimized the ribosome binding sites for E. coli overexpression with 
M. extorquens mcl.  We tested the in vitro crude extract activities in a coupled assay of mtk and 
mcl with result shown in Figure 4.2. The result shows that with the optimized rbs for M. capsulatus 
sucCD-2 and M. extroquens mcl, the crude extract showed the highest coupled activities for mtk 
mcl (pSS71r).  
As for in vivo test, we employed the acetyl-CoA auxotroph (selection scheme shown in Figure 4.3).  
During growth on glucose in minimal medium, the decarboxylation step from pyruvate to acetyl-
CoA is essential for growth since acetyl-CoA is the precursor of fatty acid biosynthesis. With this 
in mind, we searched literature for an acetyl-CoA auxotroph. At first we found the aceF knock out 
strain19, which was unable to grow in Vogel-Bonner Medium containing glucose only. However, 
the medium contained citric acid20, which, although is not an transported into E. coli, may be a 
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factor that interfere with the result. While grown in M9 medium, the cell showed behavior 
exhibited growth even in glucose only medium for poxB and pflB is still present in the strain. As 
a result, the aceF knock out strain is not an ideal host for the growth test. We then used strain 
YYC20221, which was built initially to facilitate lactate production. As such, it has all the genes 
that would direct carbon flux away from pyruvate, including pyruvate kinase (pyk), a 
gluconeogenic enzyme. Although YYC202 proved to be an acetyl-CoA auxotroph in glucose 
minimal medium, the growth rate was too slow even when acetate was fed as the positive control 
due to the loss of activity of pyk (data not shown). Besides, the pflB and poxB were only inactivated 
in the strain with only one point mutation in each of the genes, making them easily reversible 
targets of mutation back to the normal active enzyme. We, therefore, constructed an acetyl-CoA 
auxotroph in lab (SS108 and SS109) by knocking out the three genes for decarboxylation of 
pyruvate, namely aceEF, poxB and pflB (Selection scheme shown in Figure 3.2). SS108 and SS109 
are unable to be grow in glucose minimal medium unless it is supplied with additional acetate or 
acetyl-CoA or ethanol. Here we overexpressed the different mtk mcl constructs in SS109 in light 
that with higher enzymatic activities of mtk mcl, a higher growth rate will be shown. Figure 4.3 
shows the result of the bioprospection. The four newly cloned mtk(s) (Ml, Me, Ne, Mr) did not 
show any superior activities than the original mtk from Methylococcus capsulatus. However, with 
an optimized RBS and with the M. extorquens mcl (pSS71r), the rate of growth rescue was much 
improved from the original operon design (pHYm) which agreed with the in vitro result where mtk 
mcl coupled activities is highest when expressed from pSS71r. From that result, we moved on with 
the rGS-2 demonstration with the pSS71r operon design. 
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Figure 4.2.  Mtk mcl Bioprospection result. (A) The schematic of the enzyme assay of mtk mcl (B) 
In vitro specific crude extract activities of different constructs of mtk mcl. Abbreviaations: Ml, M. 
loti mtk Me mcl; Me, M. extorquens mtk Me mcl; Ne, N. europaea mtk Me mcl; Mr, M. 
radiotolerans mtk Me mcl; pSS71r, Mc mtk Me mcl; pHYm, Mc mck Rs mcl. 
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Figure 4.3. The acetyl-CoA auxotroph selection scheme and biopropecting result. (A)Black lines 
denote the native pathways. “X” denotes genes that were knocked out the strain. Blue lines denotes 
overexpressed enzymes. Yellow arrow denotes the carbon source and green arrow denotes the 
products. Enzyme abbreviations: aceEF, pyruvate dehydrogenase; poxB, pyruvate decarboxylase; 
pflB, pyruvate formate-lyase; ppc, PEP carboxylase; mdh, malate dehydrogenase; mtk, malate 
thiokinase; mcl, malyl-CoA lyase; gcl, glyoxylate carboxyligase; (B) Growth Rescue of the acetyl-
CoA auxotroph by different versions of mtk mcl. 
 
4.4.2. Producing Pyruvate and Acetyl-CoA from Malate 
To demonstrate in vivo synergetic functionality of mtk mcl and the glyoxylate degradation pathway, 
we set up a selection scheme in a strain with PEP carboxykinase, malic enzymes knock outs 
(MC41003). PEP carboxykinase and the malic enzymes are essential to synthesize gluconeogenic 
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intermediates from TCA intermediates. MC41003 is unable to grow in TCA cycle intermediates 
as the carbon source because it lacks the enzyme to convert TCA cycle intermediates into 
gluconeogenic intermediates, which are essential for growth. The rGS-2 is theoretically capable of 
making gluconeogenic intermediates, 2-phosphoglycerate, from TCA intermediates, malate. In 
order to verify the theory, we overexpressed mtk mcl along with the glyoxylate degradation 
pathway and fed fumarate as the sole carbon source. We chose fumarate instead of malate as the 
carbon source mainly because a dicarboxylic acid transporter would have to be overexpressed in 
order to transport malate into E. coli cells whereas the native C4 dicarboyxlate transporter (dauA) 
in E. coli is capable of fumarate transport22. Fumarase can then convert fumarate into malaate, 
which will in turn be splitted into glyoxylate and acetyl-CoA and through the glyoxylate 
degradation pathway, glyoxylate is converted into gluconeogenic intermediates. The result is 
shown in Figure 4.4. Either with a native gcl knocked out from the strain or without the 
overexpression of mtk mcl, the cell was unable to grow in minimal medium as the sole carbon 
source. From this, we proved that the mtk mcl along with the glyoxylate pathway functions 
synergistically in vivo. 
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Figure 4.4. The selection scheme of MC41003 and the growth rescue by overexpression of mtk 
mcl. (A) shows the selection scheme with the enzyme abbreviations: pck, PEP carboxykinase; 
maeA, maeB; malic enzymes; fumA, fumarase; mdh, malate dehydrogenase; mtk, malate 
thiokinase; mcl, malyl-CoA lyase; gcl, glyoxylate carboligase; glxR, tartrontate-semialdehyde 
reductase; glxK, garK, glycerate phosphokinase. (B) shows the average of n=3 growth curves of 
MC41003 and MC41004 harboring Mc sucCD-2 and Me mcl expression plasmids (pSS81 and 
pSS71r) in fumarate minimal medium. (i) MC41003 pSS80, (ii) MC41003pSMf00, (iii) 
MC41004 pSS80,  (iv) MC41003 pSS71r, (v) MC41003pYK, (iii) MC41004 pSS71r 
 
4.4.3. Growth enhancement of Acetyl-CoA Auxotroph with the rGS-2 
We further demonstrated the rGS-2 functions as a cycle in an acetyl-CoA auxotroph (SS108). In 
the test, we fed glucose as the sole carbon source which produces PEP through glycolysis.  With 
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ppc and mdh producing malate and mtk mcl lysing malate into glyoxylate and acetyl-CoA with 
the help of CoA, it should be enough to rescue the acetyl-CoA auxotroph. However, with only mtk 
mcl, only one molecule of acetyl-CoA will be produced from one molecule of pyruvate. On the 
other hand, with the glyoxylate degradation pathway, glyoxylate can also be recycled back to 
pyruvate giving more acetyl-CoA and thus enhances growth. The test was done under 
microaerobic conditions in a plate reader where the overexpression of mtk mcl was induced in 
strains harboring pSS80 and pSS71r. The result from Figure 4.5 is coherent with the hypothesis.  
The overexpression of pSS80 or pSS71r alone was enough to rescue the acetyl-CoA auxotroph. 
After knocking out gcl, mtk mcl can still rescue the acetyl-CoA auxotroph but at a slower rate than 
the strain the intact native gcl. Result shows that native gcl expression levels under microaerobic 
conditions is enough to enhance growth in that case. Moreover, with the growth enhancement by 
the glyoxylate degradation pathway is actually comparable with the positive control with the direct 
addition of acetate supplemented to the medium as shown in Figure 4.5. Although the synergistic 
effect is not obvious in strains harboring pSS71r probably because the activities of mtk mcl was 
not strong enough to show the effect of recycling of malate. We also noticed that strains harboring 
the higher copy plasmid pSS80, which exhibits higher mtk mcl activities, shows a faster growth 
rate, indicating that with a higher rate of acetyl-CoA production, the growth rescue is elevated and 
thus, the acetyl-CoA auxotroph can potentially be an evolution platform for the rGS-2 pathway. 
However, when we tried to measure acetate produced in the medium, we were unable to detect 
appreciable amount of acetate in the HPLC. We hypothesized two reasons for this phenomenon. 
The lack of acetate production could have been due to the fact that ppc is activated by acetyl-CoA 
and in an acetyl-CoA-deprived strain, the ppc was never active enough to produce OAA for the 
subsequent enzymes and thus acetate.  The second hypothesis was that the redox is not balanced 
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when CO2 fixation is required in this process. Even with the overexpression of formate 
dehydrogenase and the addition of formate, it is not enough to serve as an electron source for both 
NADH and ATP, especially for ATP. It is more feasible to use an ATP-balanced design as shown 
in Figure 4.1A. In order to facilitate the production of acetate, both an acetyl-CoA source to initiate 
the reaction and a driving force for reducing power is needed. Therefore, we made use of the 
butanol production strain, JCL166, developed by Shen, et al23. 
 
 
Figure 4.5. The result of the optimized selection scheme and result from acetyl-CoA growth resuce 
by Mc sucCD-2 and Me mcl expression plasmids in glucose minimal medium. . (A) The acetyl-
CoA auxotroph selection scheme for the synergetic effect of mtk mcl with gcl. Black lines denote 
the native pathways. “X” denotes genes that were knocked out the strain. Blue lines denotes 
overexpressed enzymes. Yellow arrow denotes the carbon source and green arrow denotes the 
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products. Enzyme abbreviations: aceEF, pyruvate dehydrogenase; poxB, pyruvate decarboxylase; 
pflB, pyruvate formate-lyase; ppc, PEP carboxylase; mdh, malate dehydrogenase; mtk, malate 
thiokinase; mcl, malyl-CoA lyase; gcl, glyoxylate carboxyligase; glxR, tartronate- semialdehyde 
reductase; glxK, garK, glycerate kinase; eno, enolase. (B) shows the growth curve SS108 and 
SS109 strains harboring the plasmids pSS80 and pSMf00 plasmids in glucose minimal medium. 
(i) SS108 pSS80 (ii) SS108 pSMf00 (iii) SS109 pSS80 (iv) SS109 pSMf00 (v) positive control: 
SS108 pSS80 supplemented by 10mM sodium acetate. (C) shows the growth curves of  SS108 and 
SS109 strains harboring the plasmids pSS71r and pYK. (vi) SS108 pSS71r (vii) SS108 pYK (viii) 
SS109 pSS71r (ix) SS109 pYK (x) positive control: SS108 pSS71r supplemented by 10mM sodium 
acetate.  
 
4.4.4. Growth Rescue in JCL166 Showing the Driving Force from Reducing Power Balance 
Given the above success in the synergetic rescue, we thrived to produce acetate with the rGS-2 
pathway. The acetyl-CoA auxotroph is not an ideal host for the production process due to the fact 
that the production of acetate competes with the growth and that pyruvate carboxykinase and PEP 
carboxylase both requires acetyl-CoA as the activator24. The production of acetate and growth 
requirement acetyl-CoA is in conflict with each other. Gauging into the reducing power required 
in the production process of acetate in rGS-2, we noticed that NADH is required for the cycle to 
be fully functional. Therefore, we used the strain JCL166, which, with all the fermentative pathway 
knocked out, is capable of accumulating a large amount of electrons under anaerobic conditions. 
In addition, the consumption of NADH, thus the recycling of NAD+, is a growth requirement in 
the JCL166 strain as well. The growth of JCL166 is then linked to the production of acetate under 
104 
 
anaerobic conditions. Moreoever, with pflB intact in the strain, acetyl-CoA can also be made 
through pyruvate as shown in Figure 4.1 and thus the activation of ppc will not be affected. We 
first confirmed the enzymatic activities of the rGS-2 pathway in the JCL166 strain with the 
respective coupled enzyme assays in Figure 4.5. The coupled enzyme assays showed that all the 
enzymes are functionally overexpressed in JCL166. We then tested the idea of the anaerobic rescue 
by the rGS-2 with the result of the test shown in Figure 4.6. We showed that with overexpression 
of the butnaol pathway as the positive control, the growth is retarded with increasing concentration 
of glyoxylate in the medium. However, with the overexpression of the both mtk mcl and the 
glyoxylate degradation pathway, cell growth is enhanced by the elevated concentration of 
glyoxylate, suggesting that with the consumption of and the degradation of glyoxylate through the 
overexpression of gcl-glxR-glxK, JCL166 is able to grow with the consumption of NADH through 
the degradation.  From the above result, we demonstrated the feasibility of using a JCL166 to 
create a reducing power pool to drive the rGS-2 and the production of acetate. 
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Figure 4.6. The coupled enzyme assays and the enzyme activities shown in JCL166. (A) shows 
the coupled enzyme assay schemes. Enzyme abbreviations: ppc, PEP carboxylase; mdh, malate 
dehydrogenase; mtk, malate thiokinase; mcl, malyl-CoA lyase; gcl, glyoxylate carboxyligase; 
glxR, tartronate- semialdehyde reductase; glxK, garK, glycerate kinase. (B) shows the specific 
enzymatic enzyme activites in crude extract of JCL166 harboring pSS81 and pFD254. 
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Figure 4.7. The selection scheme of JCL166 and the result of growth rescue. (A) shows the 
selection scheme of JCL166 with the rGS-2 pathway. Black lines denote the native pathways. “X” 
denotes genes that were knocked out the strain. Blue lines denotes overexpressed enzymes. Yellow 
arrow denotes the carbon source and green arrow denotes the products. Enzyme abbreviation: pflB, 
pyruvate formate-lyase; ppc, PEP carboxylase; mdh, malate dehydrogenase; mtk, malate 
thiokinase; mcl, malyl-CoA lyase; gcl, glyoxylate carboxyligase; glxR, tartronate- semialdehyde 
reductase; glxK, garK, glycerate kinase; ldhA, lactate dehydrogenase; adhE, alcohol 
dehydrogenase; frdB, fumarate reductase. (B) shows the growth curve of JCL166 overexpressing 
different combinations of plasmids under anaerobic conditions at different amount of glyoxylate.  
 
4.4.5. Production of Acetate by JC166 with Glucose in Rich Medium 
Having shown that the consumption of NADH and the recycling of NAD+ through the oxidation 
of tatrontate-semialdehyde into D-glycerate rescues the growth of the JCL166, we implemented 
the rGS-2 pathway into the JCL166 strain. Contrary to our hypothesis that the production has to 
be carried out under anaerobic conditions, our initial production test showed that the maximum 
amount of acetate production was shown in aerobic conditions. This is possibly due to the fact that 
pyruvate dehydrogenase under aerobic conditions is much more active than pyruvate formate-lyase 
under anaerobic conditions. The production result is shown in Figure 4.8. The production of acetate 
in the rich medium supplemented with glucsose is higher than theoretical value (1:3) as shown in 
Figure 4.8D. Part of the reason is that the content of TB may have been taken up as carbon source 
to produce acetate as well which would then make it necessary to eliminate the contribution of TB 
to the production process of acetate. A more controlled time course experiment was carried out to 
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compare the production of acetate from both TB only medium and TB medium supplemented with 
glucose. The difference in production of acetate between the two media would give the amount of 
acetate that was produced from glucose. The result is shown in Figure 4.9. After subtracting the 
amount of acetate that was produced from TB only medium, we found that with the overexpression 
of mtk mcl and the native level of gcl activities, the yield of acetate production from glucose was 
able to reach 2.3 mol/mol, wheras with the overexpression of the all the key enzymes, the yield 
was around 1.9 mol/mol. With this result, we did further test on whether the native level of gcl 
activities was enough to support the rGS-2 itself by knocking out gcl from JCL166. The result is 
shown in Figure. 4.10. The result shows that either with the deletion of gcl or without the 
overexpression of mtk mcl, the yield of acetate from glucose is lower than 1:2 and that either the 
overexpression or the native gcl activities alone, the yield of acetate from glucose is over 1:2. To 
further confirm that the acetate produced in the medium is attributed to glucose consumption, we 
replace the 12C-glucose with 13C-labelled glucose with the hypothesis that all the acetate produced 
from glucose will be labelled with 13C with results shown in Figure 4.11. The result was not as 
expected to have production of acetate over the theoretical 1:2 ratio when only with the 
overexpression of mtk mcl and native level of gcl that the ratio was reaching around 1:1.9. 
However, the yield is still higher than that of the negative control that was without the 
overexpression of mtk mcl showing that the rGS-2 contributed to the higher carbon yield of acetate 
from glucose and the other part of the labelled glucose contributed to growth. 
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Figure. 4.8. The production data showing the consumption of glucose and the production of acetate 
under aerobic conditions after 15 hours and anaerobic conditions after 24 hours. A) The molar 
production of acetate in JCL166 with the overexpression of the labelled plasmids. B) The molar 
consumption of glucose in the different JCL166 strains overexpressing different plasmids. C) 
Comparison of the production of acetate and consumption of glucose in g/L. D) The molar yield 
of acetate from per mole of glucose. The dotted lines represents the theoretical 1:2 ratio and the 
enhanced yield target of rGS-2, the 1:3 ratio.  
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Figure. 4.9. Time course of acetate production from TB medium supplemented with glucose 
showing the amount of acetate that was produced from glucose in JCL166. A) The glucose 
consumption by different strains of JCL166 in a time course. B) The distribution of acetate 
produced with TB or with glucose by JCL166 harboring different plasmids. (i) pSS71r pSS49f 
pFD254, (ii) pYK pSS49f pFD254, (iii) pSS71r pSMf00 pFD254. C) Time course of the acetate 
production by different strains from glucose in a time cours. D) The time course of the molar yield 
of acetate from per mole of glucose.  
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Figure 4.10. The production data showing the consumption of glucose and the production of 
acetate under aerobic conditions after 24 hours of incubation in the shaker. A) The molar 
consumption of glucose by JCL166 and SS121 harboring different plasmids. B) The different 
amount of acetate production contributed from glucose or from TB. C) Comparison of 
consumption of glucose and amount of acetate produced from glucose in wt%. D) Molar ratio of 
acetate yield produced from glucose. 
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Figure 4.11. The production data showing the consumption of C13-labelled glucose and the 
production of C13-labelled acetate under aerobic conditions after 24 hours of incubation. A) The 
molar consumption of C13-labelled glucose. B) The molar contribution of labelled and unlabeled 
acetate to the total acetate production of acetate. C) Molar ratio of acetate yield produced from 
glucose. D) Comparison of consumption of glucose and amount of acetate produced from glucose 
in wt%. 
 
 
4.5. Conclusion and Future Directions 
In all, we improved the activities of the previous activities of the mtk mcl. We designed a new 
partially reversed glyoxylate shunt and showed the synergetic effect of the expression of mtk mcl 
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with the native glyoxylate degradation pathway, which rescued the gluconeogenic auxotroph strain 
and enhanced growth rescue in the acetyl-CoA auxotroph to the positive control level. In addition, 
we demonstrated of an electron pool as a driving force to facilitate the production of acetate 
through the rGS-2. 
In order to make the pathway feasible for industrial usage, we need to show higher yield of acetate 
produced from glucose although current data suggests that the rGS-2 may have been effective in 
enhancing acetate production from glucose already. Since all the pathway enzymes are active in 
JCL166 strain, we hypothesize that the enzyme activities is not balanced to produce the desired 
amount of acetate. It is highly recommended that an rbs library should be designed to balance the 
enzymatic activities of all the enzymes in the JCL166 strain. If a higher acetate yield from glucose 
(1:4) is desired, addition source of NADH, possibly through the overexpression formate 
dehydrogenase and the addition of formate, and source of ATP will have to be considered. In 
addition to improved yield of C2 from sugar, the pathway shows a potential of a novel CO2 fixation 
pathway when supplemented by another CO2 fixation step, possibly through a pyruvate:ferredoxin 
oxidoreductase, producing one pyruvate as a result of fixing three molecules of CO2.   
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4.6. Figures and Tables 
gene 
knockout  
Verification primers (5' -> 3') 
gene 
knockout  
Verification primers (5' -> 3') 
aceEF 
TGTGGTTCTGCTTCATCTGC 
ldhA 
CTCCCACCAGATAACGGAGA 
ACGTGCAGCAGTGCTTTAGA TTTCTGGCGGATTTTTATCG 
poxB 
AAGCAATAACGTTCCGGTTG 
adhE 
CAACACCGACCTGCTCTACA 
ATGGATATCGTCGGGTTTGA AATACCGGTTCGTCAGAACG 
pflB 
CAGCGGTTTTGAGCACAGTA 
frdB 
CAACACCGACCTGCTCTACA 
GTGGCGATAGGTCACCACTT AATACCGGTTCGTCAGAACG 
gcl 
GCGGAAGAGGAGTTGATGAG 
maeA 
AATGAAATCGAACCGTCAGG 
GAGTTCCGGTGAGATGGAAA CAGAATTACGCCGGTTTTGT 
pck 
TCCGGGCAGTAGTATTTTGC 
maeB 
CATCCTGGGGATGATAATGG 
GCTATGAGCGGGAAATTGAA GCTTTCAGCGCTAAATCACC 
 
Table 4.1A Primer pairs used for verification of gene knock-outs for the said strains 
 
Strain name Relevant genotype Reference 
JCL16 
rrnBT14 ΔlacZWJ16 hsdR514 ΔaraBADAH33 
ΔrhaBADLD78 /F’[traD36 proAB+ lacIqZ ΔM15] 
Atsumi et al., 200825 
MC4100 
F- [araD139]B/r Δ(argF-lac)169* &lambda- e14- 
flhD5301 Δ(fruK-yeiR)725 (fruA25)‡ relA1 
rpsL150(strR) rbsR22 Δ(fimB-
fimE)632(::IS1) deoC1 
Peters et al, 200326 
SS108 JCL16 ΔaceEF ΔpoxB ΔpflB This work 
SS109 JCL16 ΔaceEF ΔpoxB ΔpflB Δgcl This work 
MC41003 MC4100 Δpck ΔmaeA ΔmaeB This work 
MC41004 MC4100 Δpck ΔmaeA ΔmaeB Δgcl This work 
JCL166 JCL16 ΔldhA ΔadhE ΔfrdB Shen, et al., 201123 
SS121 JCL16 ΔldhA ΔadhE ΔfrdBgcl This work 
 
Table 4.1B E. coli strains used in this study 
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Plasmid 
name 
Description Reference 
pSS49f 
ColE ori, AmpR, PLlacO1:gcl: PLlacO1:glxR: 
PLlacO1:glxK 
This work 
pSS71r 
ColA ori, KmR, LacI, PLlacO1:RBS:sucD-2:RBS:sucC-2 
(Mc):RBS:mcl (Me) 
This work 
pSS80 
ColE1 ori, AmpR, PLlacO1:sucD-2:RBS:sucC-2 
(Mc):RBS:mcl (Me) 
This work 
pSS81 
ColE1 ori, AmpR, PLlacO1:sucD-2:RBS:sucC-2 
(Mc):RBS:mcl (Me) PLlacO1:gcl:RBS:glxR:RBS:glxK (Ec) 
This work 
pFD254 
pSC101 ori, GenR, 
PLlacO1:fdh(Cb):RBS:ppc(Ec):RBS:mdh(Ec) 
This work 
pHYm 
ColA ori, KmR, PLlacO1:sucC-2:RBS:sucD-2 
(Mc):RBS:mcl (Rs) 
This work 
pSMf00 p15A ori, AmpR, LacI, empty 
Mainguet, et al., 
2013 
pYK ColA ori, KmR, LacI, empty 
Mainguet, et al., 
2013 
 
Table 4.2. Plamids and the genetic features used in this study 
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Chapter 5. Conclusion and Outlook 
 
In effort to reduce carbon emission, using glucose produced from photosynthesis as the feedstock 
for biofuel and biochemical is one way to recycle CO2 back to useful daily chemicals. A lot of the 
biochemical productions involve the intermediate acetyl-CoA for the final product production. 
However, the main way of acetyl-CoA production always involves the decarboxylation of pyruvate 
to form acetyl-CoA. The release of CO2 involved in the process counters the purpose of CO2 
recycle. To alleviate this effect, two reverse glyoxylate shunts were designed and implemented 
into E. coli with the following accomplishments described in the thesis. 
 
The Reverse Glyoxylate Shunt (1): 
1.  The reversal of the glyoxylate shunt was accomplished by the overexpression of the native 
isocitrate lyase and the heterologous overexpression of malate thiokinase and malyl-CoA 
lyase.  
2. We replaced enzymes that were thermodynamically irreversible with ATP-coupled 
enzymes (ATP-citrate lyase in place of citrate synthase and malate thiokinase coupled with 
malyl-CoA lyase in place of malate synthase) to complete the rGS-1.  
3. By knocking out the competing pathways that drains the pathway intermediates (isocitrate 
dehydrogenase) and optimizing the branch point of the pathway (overexpression of malate 
synthase), we showed the production of two C2 molecules produced from one C4 
molecules.  
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4. Growth enhancement was demonstrated in the OAA auxotroph harboring the rGS-1 with 
directed evolution.  
 
The reverse Gloxylate Shunt (2): 
1. The malate thiokinase and malyl-CoA lyase coupled activities was further improved 
through bioprospecting and rbs optimization.  
2. The rGS-2 was shown to be capable of supporting the growth in the acetyl-CoA auxotroph. 
3. The rGS-2 was capable of alleviating the redox imbalance in JCL166, which is incapable 
of fermentation and thus the recycling of NAD+ under anaerobic conditions, and rescues 
growth of JCL166 under anaerobic conditions with the addition of glyoxylate.  
4. With the overexpression of the rGS-2 pathway, we were able to show higher yield of 
acetate production than the negative control which lacks mtk mcl, the key enzyme of 
acetyl-CoA production in the rGS-2 pathway. 
 
The acetate production in E. coli from glucose is a preliminary step to carbon efficient biofuel and 
biochemical production. Moving forward, in order to apply the rGS(s), the pathway can be used 
to couple with biochemical production that involves acetyl-CoA as intermediates, such as n-
butanol, fatty acids derived chemcials. The integration of the rGS(s) into the strain genome will 
make organism a versatile, carbon efficient host to any biochemical production pathways that 
requires acetyl-CoA as the intermediate. The rGS(s), when coupled with a pathway that is capable 
of forming pyruvate through the carboxylation of acetyl-CoA, such as pyruvate:ferredoxin  
oxidorectase (PFOR), is a novel CO2 fixation pathway. However, due to limited understanding the 
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reversibility of PFOR outside of the native organism and the oxygen sensitivity of the enzyme, the 
implementation of the rGS(s) coupled CO2 fixation pathway will pose challenge for future 
researchers unless there is better understanding to PFOR or alternative pathway that is capable of 
the carboxylation of acetyl-CoA is demonstrated. 
 
